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Stem cell therapies are currently being explored for their potential in the regeneration 
of load bearing tissues, such as cartilage. Current therapies lack the ability to intrinsically 
overcome a mechanically adverse environment at implantation. To advance the 
implementation of human mesenchymal stem cells (hMSCs) for cartilage repair, the 
mechanisms by which cells “feel” and interact with their micromechanical environment 
need to be understood. Chondrogenic hMSCs develop a thin pericellular matrix (PCM), 
consisting of type VI collagen (ColVI) and proteoglycans such as decorin (DCN). The 
PCM is believed to control mechanotransduction events, acting as both a biomechanical 
and biochemical buffer. This thesis studies the functional role of ColVI and DCN through 




In the first part of the work, the biophysical role of the PCM was determined through 
comparisons of cellular deformability under uniaxial strain with or without ColVI and 
DCN knockdown. HMSCs were cultured in alginate scaffolds and were stimulated with 
transforming growth factor β for 1 to 2 weeks. We found that the PCM with ColVI 
knockdown lacked the ability to withstand applied compression and with DCN 
knockdown deformed in a strain-dependent manner. Next we analyzed the 
mechanosignaling initiation caused by a transient sinusoidal compressive load through 
studying cytoskeletal kinetics and gene expression. Altering the PCM through ColVI and 
DCN knockdown caused an increase in actin and vimentin cytoskeletal protein 
concentration that lacked a dynamic response to load. This lead to a stronger fibroblast 
growth factor gene expression in ColVI knockdown. DCN also demonstrated direct 
control over cartilage oligomeric matrix protein gene expression, through a loss of TGF-β 
regulation. These results were further demonstrated during long term compressive 
culture. Unconfined sinusoidal compressive culture revealed the highest improvement in 
material properties in knockdown samples at day 14.  
Through these studies, we demonstrated that ColVI and DCN are integral proteins in 
maintaining the structural microenvironment through protecting the cell from injurious 
deformation, maintaining cytoskeletal dynamics in response to load, and regulating the 
differentiation rate through TGF-β signaling. Finally, we demonstrated the ability to 
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Chapter 1: Introduction 
Human mesenchymal stem cells (hMSCs) have demonstrated great potential in the 
development of regenerative therapies for load-bearing tissues, such as articular cartilage. 
This is due to their ability to maintain a basal phenotype and multipotentiality during 
expansion, reducing the need for autologous chondrocytes for defect repair (10). 
Differentiation can be induced through various methods, including biochemical 
stimulation from exogenous addition of growth factors (11)  or biomechanical induction 
(12). HMSCs are dynamically sensitive, and differentiation lineage commitment will 
depend on the method of dynamic stimulation (13,14).  Currently proposed approaches 
lack the capability of controlling stem cell response to the adverse environment in the 
mechanically compromised tissue at the site of implantation. One method to overcome 
this is genetically engineering the biological response to mechanical stresses using RNAi, 
but first, the mechanisms through which cells “feel” and interact with their 
micromechanical environment need to be explored. Mechanotransduction is the process 
through which cells react to a mechanical stimulus and elicit a chemical response. 
Mechanosignaling pathways are critical to understand how cells, particularly those in 
load bearing tissues, maintain their structural environment during physiologic activity. 
The mechanotransduction events of chondrocytes and chondrogenic stem cells are not 
fully understood and need to be explored for advancement of regenerative therapies.  
Mechanical stimulation induces changes, such as increases in the cellular synthesis of 
a highly organized matrix to withstand physiologic stresses (15,16). hMSCs undergoing 
chondrogenesis create a thin layer of matrix that around the cell called the pericellular 
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matrix (PCM). The PCM consists of type VI collagen (ColVI), hyaluronan and 
proteoglycans such as decorin (DCN) (17-21). The PCM serves as both a biomechanical 
and biochemical buffer, and  controls the amount of mechanical load that deforms the 
chondrocyte as well as the biological response. The accumulative level and composition 
of the PCM is important for regulating cellular deformation, with specific components 
modulating the assembly and aggregation of other proteins. The effect of targeted gene 
knockdown of structural proteins on the PCM’s function will reveal their roles in 
chondrocyte mechanotransduction and biological responses to physiologic loading.  
The goal of this thesis was to examine the role of type VI collagen and decorin in the 
biological response to mechanical stimulation using shRNA knockdown. This work 
demonstrated that ColVI and DCN are integral in cellular mechanotransduction. These 
studies demonstrated the ability to genetically engineer hMSCs, controlling matrix 





Chapter 2: Objectives and Specific Aims 
Specific Aims 
The biochemical response to mechanical loading of chondrogenic hMSCs is believed 
to be controlled through the PCM due to its temporally specific and changing 
micromechanical environment. ColVI and DCN are believed to be important within the 
PCM due to their synthesis and accumulation during differentiation (20,22). RNA 
interference (RNAi) mediated knockdown of these proteins allows a stable continuous 
examination during chondrogenic differentiation in response to biochemical induction 
and biomechanical stimulation. An altered PCM will change the mechanotransduction 
mechanisms and therefore the biological response. The targeted knockdown of ColVI and 
DCN elucidated their roles in the complex regulation of cellular reactions to mechanical 
load.  
 
Global Hypothesis: Structural proteins within the PCM of 





Aim1:  Determine roles of type VI collagen and decorin in human mesenchymal 
stem cell biophysics during chondrogenic differentiation 
 The first aim was to determine whether chondrogenic differentiation can 
successively progress without type VI collagen and decorin within the PCM. 
Secondly, it was determined whether type VI collagen and decorin are 
essential in shielding the cells from deformation.  
Aim 2:  Determine type VI collagen and decorin's role in the mechanosignaling 
initiation and cytoskeletal kinetics of differentiating hMSC 
 The PCM is important in shielding the cell from harmful mechanical stresses. 
The second aim was to determine whether type VI collagen and decorin, while 
contributing to the micromechanical environment, also are essential in  
initiating mechanosignaling cascades in response to transient loading during 
PCM development.  
Aim 3:  Determine type VI collaegn and decorin's influence on cell-seeded alginate 
scaffold material properties and chondrogenic gene expression during long 
term dynamic compressive culture 
 The final aim of this study was to determine the roles of type VI collagen and 
decorin in the biological response to dynamic culture, analyzing the changes 





Chapter 3: Background 
3.1 Articular Cartilage 
Articular cartilage (AC) covers the ends of articulating surfaces of bones to ensure 
normal, pain-free motion and act as a shock absorber. AC is composed of 60-80% water 
(21,23,24), with the remainder being collagens, proteoglycans (PGs), and noncollagenous 
proteins (25). Only 1-2% of the final volume of cartilage is composed of chondrocytes, 
the main cell type within AC. Cartilage is avascular, aneural, and alymphatic causing 
limited self-repair (24). Chondrocytes create a highly organized matrix, giving AC the 
ability to withstand pressurization, compression, tension, and shear without failure 
(15,16,25). The cartilage matrix dissipates these mechanical loads to the cells, preventing 
cellular injury while allowing mechanical stimulation.  
Cartilage extracellular matrix (ECM) surrounding chondrocytes consists of structural 
proteins, with type II collagen in the highest quantity (21,25), that form an oriented 
meshwork providing tensile strength and resiliency to mechanical stress. PGs within the 
ECM are negatively charged, due to their attached glycosaminoglycan (GAG) side chains 
and aid in the hydration of the tissue providing the ability to pressurize and withstand 
impact loading (24). PGs are either large aggregating molecules (aggrecan) or small 
proteoglycans, such as biglycan, decorin, and fibromodulin (25). Aggrecan is the most 
abundant PG present in the ECM of articular chondrocytes (17). Decorin and 




3.2 OA breakdown of ECM 
Osteoarthritis (OA) is one of the most common forms of joint disease, resulting in 
tissue failure of articular cartilage (26). During OA, there is a biochemical and 
biomechanical breakdown of cartilage ECM. PGs are degraded (fig. 3.1), resulting in a 
loss of fixed charge (27) and stiffness (28) and collagen breakdown results in a 
mechanical loss of integrity (Fig. 3.1) (27). This ECM degradation creates fissures and 
focal defects along the articulating surface of cartilage, which are exasperated during 
physiologic loading (1). This may be due to the inability of the chondrocytes to respond 
to anabolic signals (29). OA symptoms include cellular hypertrophy and terminal 
differentiation (29)
 
coupled with increasing expression of type X collagen, alkaline 
phosphatase and the transcription factor runx2 (27). The breakdown of ECM during OA 
could be due to the imbalance of anabolic (pericellular matrix (PCM) proteins) and 
catabolic enzymes (metalloproteinase-2 (MMP-2) (30), tissue inhibitors of 
metalloproteinases-2 (TIMP-2) (30,31), MMP-7 (31), MMP-13, A Disintegrin And 
Metalloproteinase with Thrombospondin Motifs-4 (ADAMTS-4), interleukin 1-β (IL-1β) 




Fig. 3.1: OA degradation of cartilage seen in (A,B,C) is caused by a decrease in proteoglycan and 
collagen synthesis. Breakdown of cartilage causes fibrillation and focal defects (indicated by red 
arrow).  Histological staining of cartilage shows a high concentration of proteoglycans 
(D)indicated by safranin-o staining (red, proteoglycans) which decreases in OA cartilage (E). 
(Adapted from Wilusz, R, 2013 (1)).  
3.3 Regenerative Therapies 
Current regenerative treatments for OA include debridement (33), drilling (34) and 
autologous chondrocyte implantation (ACI). These treatments mainly result in 
 8 
 
physiologically weaker fibrocartilage. ACI, while showing better mechanical stability, 
still has limitations of minimal autologous chondrocytes retrieved, loss of phenotype 
during in vitro expansion, and donor site atrophy (10,35). Chondrocytes implanted into a 
defect within articular cartilage must overcome an adverse environment in which 
physiologically harmful mechanical stresses are present. Cell seeded biosynthetic 
matrices have been developed to protect the cells from excessive mechanical loading and 
aid the re-differentiation of chondrocytes expanded in monolayer (33,36,37).   
Chondrocytes or progenitor cells have successful matrix synthesis (of type II collagen 
and PGs) when seeded in a three-dimensional matrix (38). To improve cartilage repair, 
growth factors, cytokines, and hormones have been incorporated in 3D scaffolds, such as 
transforming growth factor-β3 (TGF-β3), fibroblast growth factor (FGF), insulin growth 
factor (IGF), platelet derived growth factor (PDGF), and bone morphogenetic proteins 
(BMPs) (39). Hydrogel biosynthetic scaffolds for articular cartilage repair have had 
success with cell proliferation and cartilage ECM synthesis (40,41), but still lack the 
ability to fully maintain a chondrocyte-like phenotype within the scaffold and reach 
similar mechanical properties to native tissue. These scaffolds are composed of various 
forms of materials, focusing on alginate (18,40,42), agarose (17,43,44), hyaluronic acid 
(41,45,46), and collagen (47) hydrogel cultures. These scaffolds maintain round cell 
shape, allow for nutrient delivery, and can be modified to fit within the defect site of the 
articular cartilage. To further mimic physiologic conditions, these hydrogels can be 
modified to incorporate chondroitin sulfate and other ECM proteins (40).  
Mechanical stimulation of these tissue engineered constructs (TECs) form a more 
functionally relevant construct for implantation. Chondrocytes are mechanically sensitive 
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and respond to different mechanical loadings with increases in synthesis of types I and II 
collagen, aggrecan, and versican under dynamic compression in culture (39). TECs are 
designed to control gene expression response to maintain chondrocyte phenotype as well 
as to control the application of mechanical stresses (48). This external control over the 
microenvironment is one way to control a cell's biological response to aid in tissue repair. 
HMSCs collected from bone marrow aspirates can be expanded and then manipulated 
along the chondrogenic lineage (49,50) for repair of OA cartilage, but currently lack the 
ability to completely repair the tissue to its original physiologic function. HMSCs are 
implanted into TECs or directly into repair sites to repopulate the diseased location (fig. 
3.2), but create a different PCM and ECM than autologous chondrocytes (20). This 






Fig. 3.2: Schematic of different methods of stem cell delivery into diseased osteoarthritic 
cartilage. MSCs can be directly injected into the defect site or seeded into specifically designed 
TEC scaffolds for implantation. TEC scaffolds improve matrix elaboration, differentiation, and 
mechanical properties to overcome the adverse environment at implantation (2). (As adapted 
from Noth, U, 2008 (2)). 
3.4 hMSCs undergoing Chondrogenesis 
HMSCs have the ability to commit to a lineage through both biomechanical 
(13,14,51,52) and biochemical induction (11). Varying methods of culture have been 
studied, including pellet (38,49) and hydrogel cultures (22,53). Gene expression during 
differentiation of hMSCs is temporally specific (fig. 3.3A). Initial upregulation of 
adhesion and signaling molecules such as integrins, fibronectin, TGF-β1, TGF-β2, TGF-
β3, BMP-4, BMP-5, SMAD4, EGF, VEGF, FGF-2, and Sox9 is seen (3). These 
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molecules can be analyzed to determine the effect of different mechanical and 




Fig 3.3: (A) Genes expressed during chondrogenesis at different stages of differentiation. Various 
studies have broken chondrogenic differentiation into four stages during in vitro culture. (Peak 
expressions are indicated by bold type). (B) During chondrogenic differentiation, GAGs, 
proteoglycans and type II collagen accumulate around the cell. GAGs are stained with Safranin-O 
and aggrecan and type II collagen were stained with immunohistochemistry. (As adapted from 
Chen, W, 2009 (3) and Xu, J, 2008 (4)) 
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The form of mechanical loading applied to hMSCs will vary their lineage 
commitments. HMSCs dynamically pressurized for short term durations initiate 
chondrogenesis, in contrast to dynamic tension which initiates osteochondrogenesis 
(51,53). The degree, frequency, duration, and manner of mechanical loading can be 
sensed by hMSCs thereby affecting their gene expression. Intermittent unconfined 
dynamic compression or pressurization stimulates endogenous TGF-β cellular release 
causing upregulation of type II collagen and aggrecan (42,52). This improves 
chondrogenesis in short durations, but inhibits chondrogenesis long term with a decrease 
in GAG and collagen content, reaching terminal differentiation with expression of type X 
collagen
 
when not supplemented with TGF-β3 (54,55). To better achieve chondrocyte 
phenotype long-term, chemical stimulation using the TGF family is needed.  
Chondrogenesis can be initiated with dexamethasone and members of the TGF family 
(11,17,49,52) when added to formulated culture medium in vitro. These upregulate sox9 
(22,38), type II collagen (col2a1) (22,49), and aggrecan (acan) gene expression as well as 
secretion of a type II collagen and proteoglycan rich pericellular matrix (fig. 3.4) (17,49). 
Melhorn hypothesizes that cells undergo genetic programming towards the chondrogenic 
lineage within three days of growth factor stimulation. PCM accumulation increases with 
growth factor treatment and shows dependence on concentration (11,42). When TGF-β is 
inhibited, chondrogenic markers are also inhibited, proving the integral role of growth 
factors (42). Chondrocyte phenotype is maintained with continued growth factor 
conditions and three dimensional culture conditions forming a type VI collagen rich PCM 
after 2 weeks (11,22). With increasing amounts of sGAGs and collagens secreted during 
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chondrogenic induction (fig. 3.3b), the mechanical properties of the scaffold will increase 
(55).  
 
Fig. 3.4: Schematic of developing PCM around chondrogenic hMSCs. The PCM is composed of 
type VI collagen (ColVI), decorin (DCN), biglycan (BGN), aggrecan, and hyaluronan. 
Mechanical and chemical signaling pathways interact complimentarily when 
stimulated separately. Chondrogenesis is impaired when both stimulations are applied to 
hMSCs in long-term culture (54,55). Stimulation with TGF-β3 while undergoing 
intermittent long-term dynamic loading results in a lower amount of GAGs, collagen, and 
cell proliferation when compared to free swelling controls (54,55). Mechanical properties 
are also weakened (55). HMSCs treated with TGF-β3 for three weeks before long-term 
dynamic loading improved chondrogenesis and maintained chondrocyte phenotype over 
6 weeks (55). The interplay between mechanical stress and acan and sox9 expression is 
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complex and temporally dependent (54). Not only is the frequency and duration of 
loading important in regulating chondrocyte phenotype, but relaxation periods between 
loading also impacts chondrogenic gene expression. Constructs given longer relaxation 
times between cyclic loading showed improved synthesis of type II collagen and 
aggrecan
 
(52). Mechanical stimulation improved matrix synthesis and homogeneity 
throughout agarose constructs while also increasing the equilibrium modulus (55). TEC 
mechanical properties improve with mechanical stimulation through uniform matrix 
synthesis (55).  
Differentiation of hMSCs into physiologically functional chondrocytes need correct 
temporal applications of chemical and mechanical stimuli. The methods through which 
chondrogenesis is induced affects the new tissue being synthesized. Intrinsic control over 
the micromechanical environment of hMSCs undergoing chondrogenesis could have 
long-term effects on cellular protein synthesis and the mechanical properties of the tissue 
as a whole.  
3.5 PCM components 
The PCM is a thin layer surrounding chondrocytes and chondrogenic hMSCs, ranging 
between 2-6 microns thick (17,21,22). The PCM and chondrocyte together form a 
functional unit called a chondron, as seen in fig. 3.5 (19,21). The PCM is formed during 
cartilage formation, being found in young rats (fig. 3.5). 
 Acting as a biomechanical buffer, the PCM shields the cell from deformation which 





Fig. 3.5: Immunostaining for type VI collagen demonstrating the PCM during cartilage 
development at (A) 1 month and (B) 11 months of growth in wild-type mice. Arrows point to 
type VI collagen staining within the PCM of chondrons in the articular cartilage. Adapted from 
Alexopoulos, L, 2009 (5)).  
Cellular deformation decreases compared to applied bulk deformation of scaffolds 
with increasing amounts of PCM (22). The PCM’s mechanical stability is frequency 
dependent (42), which may be due to fluid flow within the PCM or to its viscoelastic 
biphasic behavior (19). The increasing amounts of matrix accumulated during in vitro 
culture show an increase in strength and a decrease in viscoelastic properties associated 
with increased deposition of proteoglycans and collagen (42). 
In addition to acting as a mechanical stabilizer, the PCM also aids maintenance of 
chondrocyte phenotype biochemically. The PCM sequesters TGF-β and latent TGF-β 
binding proteins in the fibrillar network (3,21). Sequestration of growth factors 
immediately surrounding the cell allows for ready availability when needed. 
Chondrocytes isolated with their PCM intact have a higher expression of type II collagen 
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and proteoglycans and lower expression of type I collagen than isolated chondrocytes 
(18). Growth factor availability and therefore stimulation is not only controlled through 
sequestration capabilities, but through the permeability of the PCM which is lower than 
the surrounding ECM (19). Precise control over the micromechanical environment’s 
composition surrounding chondrocytes may aid in controlling mechanotransduction 
signaling events and the cellular response to mechanical stress.  
3.6 Type VI Collagen and Decorin 
Type VI collagen is a beaded filamentous heterotrimer fibril, about 125 nm in length 
consisting of three different α-chains (56) (α1(VI), α2(VI), and α3(VI)) that create a triple 
helical domain (57). These helical fibrils form dimers and tetramers intracellularly before 
being secreted into the PCM and assembling into the microfibrillar network (fig. 3.6) 
(58). PGs bind the PCM to the ECM through type II and VI collagen interactions (17,59).  
 
Fig. 3.6: ColVI microfibrils form a branched network. Red arrows indicate collagen bands and 
yellow arrows indicate decorin proteoglycans that “decorate” ColVI (Adapted from Keene, D, 
1988 (6)).  
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The basketlike network of type VI collagen is bound to the cell membrane through 
integrin receptors, NG2 receptors (membrane bound chondroitin sulfate PGs) and 
hyaluronan (60). These cell membrane attachments may initiate a mechanosignaling 
cascade as a response to mechanical stimulation. Type VI collagen is exclusively found 
in the PCM of chondrocytes (20,57) and is maintained with low levels of transcription 
(20). Type VI collagen isn’t necessary to maintain an “intact” PCM (5), but a PCM 
lacking type VI collagen decrease in stiffness, measuring a lower Young’s modulus. Mice 
lacking type VI collagen also show a faster development of OA with increased 
fibrillation and focal defects along the surface of the articular cartilage (fig. 3.7 ) (5).   
 
Fig. 3.7:  OA progresses in type VI collagen knockout mice. Images shown are hematoxylin and 
eosin staining of femoral cartilage from 11 month old mice of (A) wild type, (B) heterozygous, 
and (C) knockout mice. Arrows point to fibrillation of articular cartilage surface within the 
knockout model. (Adapted from Alexopoulos, L, 2009 (5)). 
Decorin is a ubiquitous small leucine rich proteoglycan (SLRP), consisting of a core 
protein with two dermatan sulfate chains attached (28,61). These GAGs aid in controlling 
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the collagen network spacing and fibril diameter (28). Decorin can bind to multiple 
collagens simultaneously (61), organizing the fibrillogensis of collagen (fig. 3.6), as well 
as the structure of the collagen network. Knockout models of decorin result in an 
upregulation of biglycan (BGN), which is a PG similar to decorin but with three 
dermatan sulfate side chains. This shows a regulatory or a compensatory effect of decorin 
on other PCM PGs (28,61). Biglycan shares binding sites on collagen proteins with 
decorin, but has a lower affinity, causing a lower involvement in PCM and ECM 
organization (61). Decorin is involved in the sequestration of TGF-β3, FGF-2, TNF-α, 
PDGF, and IGF-1 (61,62) and also has been associated with cell proliferation signaling 
(61), causing the cell to cease proliferation and enhance matrix synthesis.  
3.7 Mechanotransduction and signal transduction events 
Mechanical stimulations affect chondrocyte biological processes and are involved in 
tissue remodeling to maintain cartilage homeostasis. Various studies have examined the 
effects of substrate stiffness (48), 3D culture (55), and mechanical stimulations(63-65) on 
chondrocyte response. Determining the pathway through which cells feel their 
mechanical environment and create a chemical response will aid the development of 
TECs to better accommodate cell phenotype. 
Isolated chondrocyte systems have been used to determine gene expression response 
to loading. The most frequently used are agarose or alginate constructs, because they 
regain chondrocyte roundness as well as providing a homogenous environment 
completely surrounding the cell (22,63,66) . Applying either unconfined or confined 
compression to the hydrogel constructs resembles physiologic loading to analyze gene 
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expression and matrix accumulation
 
(53,55,67). Compression stimulates the activation of 
signaling pathways involving p38, mitogen-activated protein kinases (MAPK), cFos and 
cJun (63). ERK activated FGF2 and specific proteoglycans within the PCM have also 
been analyzed as potential mechanotransducers (68). The role of the PCM has been 
analyzed in mechanotransduction events through isolation of whole chondrons compared 
to singular chondrocytes (69).  
Within cartilage, compression of the tissue causes a decrease in volume and surface 
area (16). A possible mechanism for initiating mechanosignaling is nuclear deformation 
during mechanical loading (70,71), which is seen to increase with culture time and PCM 
accumulation. Another mechanism would be cytoskeletal reorganization (42). Expression 
of RhoA and actin filament polymerization is associated with dedifferentiation and 
inhibits the activity of sox9 (72). Chondroprogenitor cell culture in alginate maintains 
low levels of actin polymerization and RhoA signaling, with the cell sensing the 
maintained round phenotype in culture (72). With matrices of increasing stiffness, 
chondrocytes lose their roundness, rearrange stress fibers in line with created focal 
adhesions (48),
 
decrease synthesis of aggrecan and type II collagen, and increase 
proliferation, shifting towards a more hypertrophic and osteogenic phenotype (20). These 
systems, while establishing the relationship between varying forms of loading and 
chondrocyte response, do not elucidate the roles of individual components during the 
signaling cascade. 
Targeted subtraction of varying proteins surrounding hMSCs undergoing 
chondrogenesis can help determine functional roles at varying points of chondrogenic 
mechanosignaling. Different approaches to analyzing chondrocyte mechanotransduction 
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can include disruption of the PCM, intracellular signaling cascade, and transmembrane 
disruption (fig. 3.8) (7). RNA interference (RNAi) is one method of specific protein 
knockdown which can be used to analyze the mechanotransduction pathway.  
Understanding the mechanism through which chondrocytes feel and respond to 
mechanical stress will improve design of tissue engineered constructs.  
 
Fig. 3.8: Mechanotransduction can be analyzed through targeted disruption of pericellular matrix 
proteins using RNA interference. (Adapted from Hsieh, A, 2010 (7)). 
3.8 RNA interference and shRNA lentiviruses 
RNAi is an endogenous mechanism to protect against viral infection and insertable 
genetic elements as well as to regulate gene expression (73). This system is activated in 
mammalian cells when a long double stranded RNA (dsRNA) is detected within the cell 
(73). The RNase III-like enzyme Dicer cleaves the long dsRNA into 21-23 bp long short 
interfering RNAs (siRNAs) with 2- to 3- nucleotide long 3’ overhangs (73-75). These 
siRNAs join with the RNA-induced silencing complex (RISC) where the sense and 
antisense strands of the siRNA are separated. The antisense of the siRNA guides the 
RISC to the target gene’s transcript for homologous sequence-specific cleavage (73,75) 
silencing the gene.  
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RNAi can be initiated through chemically introduced siRNAs, which are able to 
suppress gene expression for up to a week (73,75) but are transient in nature, having short 
half-lives. The effectiveness of siRNAs are concentration dependent and is directly 
related to the amount of cell division occurring. SiRNAs also must be synthetically 
created, becoming a costly method of gene suppression
 
(74). Lentiviral delivery of a 
small hairpin RNA (shRNA) construct into the host’s genome allows a stable delivery of 
siRNAs to the cell for long-term activation of RNAi in a cost effective and rapid manner 
(73,75).The shRNA transcript activates the RNAi mechanism by first severing the loop 
sequence with Dicer before initiating the RISC sequence (fig.3.9)
 
(74,75). The shRNA 





Fig. 3.9: shRNA initiated RNAi. shRNA sequences are inserted into the human genome using 
lentiviral vectors. mRNA folds on itself created a dsRNA initiating the endogenous RNAi 
mechanism that recognizes and degrades target mRNA
 
(8). 
The level of knockdown created by an shRNA lentiviral vector is dependent on the 
positional insertion of the viral DNA, the level of hairpin expression, the processing of 
the shRNA into siRNA (75)
 





constructs must be homologous to the target gene (73). To ensure avoidance of off-target 
effects, BLAST searches of all used shRNA sequences using the NCBI website must be 
done
 
(74). Selected regions should have non-repetitive sequences, no intronic sequences, 
no long base runs (in order to avoid slippage), and be around 50% GC content for 
stability.  The un-translated regions of the gene should also be avoided and should be at 
least 50-100 nt downstream of the start codon
 
(74). ShRNA sequences consist of two 
stem sequences that are complementary and each 19-29 nt long with a 4-23 nt loop 
sequence separating the stems
 
(74). These sequences should be screened for 
effectiveness, since these guidelines do not ensure complete knockdown of target genes
 
(74). Manipulating the expression of specific genes allows the examination of their 
functional roles and allows intrinsic control over mechanotransduction events, 
engineering the cell’s sensitivity to mechanical stress. 
RNAi can be utilized for reverse genetics to observe the function of specific genes or 
proteins through disruption (75). Due to incomplete silencing of transcribed genes, RNAi 
suppression is considered a “knockdown” as opposed to a “knockout” system. Long term 
effects of gene suppression for therapeutics have not yet been studied, with the possibility 
of causing oncogenesis. ShRNA lentiviral vectors remain useful in vitro, while further 
research needs to be conducted for in vivo implementation (15).  
3.9 Cellular Engineering 
Genetically engineering chondrocyte function has been attempted to enhance 
chondrogenesis, and to improve functional tissue repair. Genetic engineering of both 
autologous chondrocytes and hMSCs has been explored to determine if genetically 
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changing a cell to produce a specific microenvironment will improve tissue repair 
(28,76). The use of lentiviral delivery to suppress aggrecanases (77), or adenoviral 
delivery to suppress type I collagen and upregulate TGF-β1 (78), has recovered the 
chondrocyte phenotype lost during expansion in vitro (76). Maintenance of the 
chondrocyte phenotype is important in cell based cartilage engineering and learning to 
manipulate the phenotype for long-term maintenance will overcome adverse 
environments for defect repair. Viral vectors have shown potential for tissue engineering 
purposes, both to improve defect repair and to control matrix synthesis of genetically 
modified cells.  
The functional roles of specific proteins directly surrounding chondrocytes has been 
examined with lentiviral vectors as well. Chondrogenic mechanosignaling has also been 
examined through overexpression or silencing varying proteins (72,79). Over-expression 
of DCN and its mutated core protein in chondrocytes investigated its role in ECM 
organization and its mechanical contribution to cartilage properties (28). The 
cytoskeleton was found to be important in internal chondrogenic signaling, with silencing 
of vimentin or protein kinase A (77) and overexpression of RhoA (72) impeding 
chondrogenesis. Type VI collagen has been successfully knocked down in mammalian 
cells using transfected shRNA constructs to create a transgenic animal (80). The role of 
integrins in the dedifferentiation of chondrocytes has also been studied (67).  
My research utilized this technology to examine the roles of proteins at varying points 
in mechanotransduction through targeted disruption. Changing a cell’s response to 
mechanical loading intrinsically could help in overcoming adverse environments as well 
as improving a cell’s adaptation to a tissue engineered construct for in vivo loading. This 
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is also a stable method to determine these proteins' roles in stimulating protein synthesis 
to mechanical loading before and after PCM aggregation. 
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Chapter 4: Roles of type VI collagen and decorin in human 





The use of human mesenchymal stem cells (hMSCs) in regenerative medicine has the 
potential to repair damage in load bearing tissues such as articular cartilage (57,81), 
reducing the need for autologous chondrocytes. During chondrogenesis, hMSCs develop 
a pericellular matrix (PCM) that is rich in type VI collagen (ColVI) (21,60,82), 
fibronectin (17,82,83), hyaluronan (21,84), and proteoglycans (PGs) such as aggrecan, 
decorin (DCN), and biglycan (BGN) (17,82). This thin 2-6 micron layer of matrix acts as 
both a biomechanical buffer (42,84), controlling the amount of deformation applied to the 
cell (16,22,69), as well as a biochemical conductor, presenting the cell with growth 
factors and signaling molecules (3,21,22). The PCM is believed to modulate the 
mechanoresponsiveness of chondrocytes and chondrogenic hMSCs, but the exact roles of 
the individual PCM proteins have yet to be determined.  
In articular cartilage, type VI collagen is found exclusively in the PCM surrounding 
chondrocytes (60,83) and is maintained through low levels of transcription, forming a 
microfibrillar network once secreted from the cell (22,58,60,82,83).  
 
1
Accepted for publication: Twomey JD, Thakore PI, Hartman DA, Myers EGH, Hsieh AH.  “Roles of 
type VI collagen and decorin in human mesenchymal stem cell biophysics during chondrogenic 
differentiation.” European Cells and Materials. 
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ColVI's interactions with the cell membrane at varying locations make it a primary 
candidate as a mechanotransducer (60,85,86). This complex network assembles and binds 
to the surrounding extracellular matrix (ECM) through interactions with type II collagen, 
aggrecan, and hyaluronan with aid from PGs such as DCN, BGN, as well as type IX 
collagen (6,17,58-60,82,87). 
The PCM has shown direct control over cellular phenotype, as chondrocytes isolated 
without a PCM exhibit a phenotypic change characterized by greater col1a1 and lower 
col2a1 expression than those isolated with a native PCM (18). The metabolic activity of 
hMSCs undergoing chondrogenic differentiation changes with PCM development and is 
also different from that of mature chondrocytes (17,83). Therefore it is believed that the 
PCM directly surrounding chondrogenic hMSCs is temporally changing and complex, 
with the microenvironment composition influencing chondrogenic potential and response 
(18,69,83).  
Biomechanically, the developing PCM surrounding both mature chondrocytes and 
differentiating hMSCs has been found to reduce cell deformation in hydrogels under 
applied compression (22,42,84). Protein deposition and biosynthesis progressively alter 
PCM material properties, causing increases in stiffness and elastic-like response (42). 
The ability of the PCM to help articular chondrocytes resist deformation has been shown 
to depend on hyaluronan during initial PCM assembly, and speculated to depend on 
collagen and other matrix components at later time points (84). Native chondrocytes with 
their PCM, which have been termed chondrons, exhibit a unique viscoelastic response to 
compression due to mismatched stiffnesses among the chondrocyte, its PCM, and the 
cartilage ECM (88).  
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Toward an improved understanding of how individual components of the PCM 
biochemically and biophysically regulate hMSCs during chondrogenesis, our current 
study sought to elucidate the roles of ColVI and DCN in resisting cellular deformation as 
well as their relationships with other PCM gene expression. We determined the function 
of these specific proteins through targeted subtraction using shRNA-mediated RNA 
interference (RNAi) (75). Overall, we found that knockdown of ColVI and DCN 
differentially altered PCM accumulation, expression of other PCM components, and cell 
deformation in hydrogels. These results demonstrate that the microenvironment of 
chondrogenically differentiating hMSCs can be controlled using genetic engineering 
techniques to modulate PCM composition.   
4.2 Materials and Methods 
4.2.1 Cell Culture 
Passage 2 hMSCs were obtained from Lonza (Lonza, Walkersville, MD) and were 
expanded in monolayer according to the manufacturer’s protocols, subculturing with 
growth media (GM): high glucose DMEM (HG-DMEM) (Gibco/Invitrogen, Carlsbad, 
CA) supplemented with 10% fetal bovine serum (FBS) (Gibco), 100U/mL 
penicillin/streptomycin (Gibco), 1% MEM non-essential amino acids (Gibco), and 4mM 
L-Glutamine (Invitrogen). Cells were cultured in monolayer at 37°C with 5% CO2, with 
media changes three times per week until passage 4 or 5, at which point they were used 
experimentally. Experimental and control groups were lifted from monolayer with 0.25% 
trypsin-EDTA (Gibco), centrifuged at 600xg for 5 minutes before being re-suspended in 
a 2% (w/v) alginate solution (Research Products International, Mount Prospect, IL) at a 
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concentration of 2.0 x 10
6
 cells/mL. Cells were expelled drop-wise into a 102mM CaCl2 
solution using a 22 gauge needle and allowed to cure for 10 minutes. Alginate-hMSC 
beads were cultured in either GM or chondrogenic induction media (CM) containing HG-
DMEM, ITS Universal Culture Supplement Premix (BD Biosciences, San Jose, CA), 
10nM dexamethasone, 50µg/mL L-ascorbic acid (Sigma), 40 µg/mL L-Proline (Sigma), 
100U/mL penicillin/streptomycin, 1mM sodium pyruvate, 0.584 g/mL L-glutamine, and 
10ng/mL TGF-β3 (Lonza). Beads were cultured for 1, 2, or 4 weeks post seeding at 37°C 
with 5% CO2. 
4.2.2 Lentivirus Preparation 
21-23 nt shRNA sequences were designed using RNAi Codex (web ref. 1) from either 
human col6a1 [Gen Bank: NM_001848] or human dcn [GenBank: NM_001920] mRNA.  
Stem-loop-stem shRNA constructs were created, annealed to create complimentary 
oligos, and cloned into a lentiviral vector containing a blasticidin resistance gene with a 
U6 promoter and a Pol III termination sequence. The BLOCK-iT U6 RNAi Entry Vector 
Kit and the BLOCK-iT Lentiviral RNAi Expression System (Invitrogen, Carlsbad, CA) 
were used to generate shRNA constructs and  packaged into a replication-deficient 
lentivirus (denoted shColVI A-E and shDcn A-F) using 293FT cells, Lipofectamine 2000 
and a manufacturer-supplied packaging mix (Invitrogen). The chosen sequences are listed 
in Table 4.1. A lentiviral expression vector containing the gene for GFP was prepared in 
parallel using the Vivid Colors pLenti6.2-GW/EmGFP kit (Invitrogen) for a lentiviral 
control. Virus-containing supernatants were harvested 72 hours post transfection and 
stored at -80°C until used experimentally.  
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4.2.3 shRNA Transduction 
For initial screening trials to identify optimal shRNA viral vectors, hMSCs were seeded 
at 60,000 cells/well in tissue culture treated polystyrene 6-well plates. Monolayers of 
hMSCs were infected with lentiviral particles in the presence of 6µg/mL Polybrene 
(Sigma) to aid in transduction efficiency. Each well was incubated with 100µL of either 
an shColVI (A-E) or an shDcn (A-F) vector for 24 hours. Cell monolayers were then 
washed and maintained in GM culture without selection for 1, 5, 8, or 14 days post 
infection, at which point gene expression was assessed.  
 In titering experiments, hMSCs were seeded at 60,000 cells/ well in in tissue 
culture treated polystyrene 6-well plates as previously described. hMSCs were infected 
with 100µL of either shColVI-D, shDcn-F(identified from our screen; hereafter labeled 
shColVI and shDcn, respectively), or the GFP control vector in the presence of 6µg/mL 
Polybrene (Sigma) to aid in transduction efficiency. The following day, virus was 
removed and cells were incubated for 24 hours in GM. To select for a pure population of 
transduced cells, monolayers were incubated with GM containing 12 µg/mL of 
blasticidin for 24 hours. We performed extensive preliminary sensitivity tests to identify 
this short-high intensity treatment for minimizing adverse effects of blasticidin culture. 
After transduced cell selection, cells were harvested from monolayer and flash frozen for 
DNA quantification using a Quant-iT PicoGreen dsDNA assay (Invitrogen, Carlsbad, 
CA). 
In actual experiments, each well was incubated with either shColVI, shDcn, or the 
GFP control vector at a multiplicity of infection (MOI) of 1 for 24 hours. After virus 
 32 
 
removal, cells were incubated with GM containing 12 µg/mL of blasticidin for 24 hours. 
Blasticidin-free shRNA-infected control and non-infected control hMSCs were cultured 
in parallel. Some hMSCs were cultured for 1, 4, 7, or 14 days post-infection for gene 
expression studies. Some blasticidin-selected pure populations were trypsinized for 
alginate bead culture 24 hours post selection (day 0).  
4.2.4 Determination of Viral Efficacy (Titering) 
 To determine the concentration of viral particles within the viral supernatant, a 
titering assay determines the number of cells transduced with the lentiviral vector. The 
titer of a virus determines the concentration of infecting viral particles, or titering units 
(TU), in suspension. Harvested cell samples underwent five freeze-thaw cycles for cell 
lysis, were combined with PicoGreen reagent, and fluorescence was read using a 
SpectraMax M5 plate reader (Molecular Devices, Sunnyvale, CA). Percentage of 
transduced cells was determined using a cell standard from PicoGreen assay to calculate 
the number of cells unaffected by the blasticidin resistance which indicates successful 
transduction. The titer (TU/mL) for each virus was calculated using the following 
equation: T= (% transduced cells *the number of seeded cells)/ dilution of viral 
supernatant within media (mL/mL).  
4.2.5 Cell Viability 
To determine the viability of cells in alginate beads, at each time point per sample two or 
three beads were centrally cut and transferred to a working solution of of 5-
chloromethylfluorescein diacetate (CMFDA) and ethidium homodimer-1 (EthD-1) 
(Invitrogen) and counterstained with 4',6-diamidino-2-phenylindole (DAPI) (Invitrogen). 
 33 
 
From the cut face of the beads, ten confocal fluorescence image stacks of 30 µm depth 
were taken at 100x magnification with a Nipkow (spinning) disk-equipped Olympus 
IX81 microscope. Viability was assessed on sections using channel separation and 
threshold particle analysis using ImageJ (NIH). All results are expressed as a percentage 
of total cells that are viable (green only).  
4.2.6 Gene Expression 
Gene expression was quantitatively assessed as previously described (89). At each time 
point, cells (shColVI, shDcn, and GFP transduced, along with a non-infected hMSC 
control) were released with a 100 mM sodium citrate, 30 mM EDTA solution, spun down 
and re-suspended in a buffer solution containing β-Mercaptoethanol (Fisher Scientific, 
Pittsburgh, PA) before flash freezing. RNA was isolated (RNeasy Micro, Qiagen, CA) 
and total RNA was reverse transcribed. Gene expression was analyzed using qRT-PCR 
(MyiQ System, BioRad, CA) with primers designed for human genes (Table 4.2) using 











































Table 4.2: Sequences of primers used for qRT-PCR. 
All primer amplification efficiencies were determined using linear regression 
efficiency methods and were determined to be between 91.2% and 108.2% efficient 
(R
2
>0.99) (90). Expression levels for acan, sox9, bgn, col6a1, col6a2, col6a3, dcn, 
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col9a2 and housekeeping gene GAPDH were analyzed using the ΔΔCt method. Cycle 
threshold (Ct) values were averaged and ΔCt was calculated by subtracting the average 
Ct values of GAPDH from those of the gene of interest (ΔCt col6a1=Ct col6a1- Ct 
GAPDH). ΔΔCt for each gene of interest was determined by subtracting the designated 
control ΔCt from the experimental ΔCt at each time point (i.e. ΔΔCt col6a1D7 = (ΔCt 
col6a1shColVI, D7 – ΔCt col6a1GFP, D7)). Relative gene expression levels (fold difference) 
were computed though the exponential relation 2
-ΔΔCt
  (91).  Data are shown as average 




) ± range. 
4.2.7 Western Blotting 
To quantify protein translation, cells were released from alginate as described above. 
Samples were re-suspended in a lysis buffer (50 mM HEPES (Fisher), 150 mM sodium 
chloride (Fisher), 1% Triton X-100 (Ricca Chemical Compant, Arlington, TX), 1mM 
EDTA (Fisher), 10mM Na-pyrophosphate (Fisher), 10% glycerin (Fisher)) with a 1:100 
concentration of protease inhibitor cocktail (Fisher Scientific) to precipitate out the 
proteins. A portion of the protein supernatant was separated for a modified Lowry assay 
to determine protein concentration using a Folin-Phenol color reaction detected by a ND-
1000 Spectrophotometer (Nanodrop, Wilmington, DE). The remaining supernatant was 
mixed 1:1 with a loading buffer (13% (v/v) Tris-HCl, 20% (v/v) glycerol, 4.6% (w/v) 
SDS, 0.02% (w/v) bromophenol blue, 200mM dithiothreitol). SDS-PAGE was performed 
using pre-cast Criterion Tris-HCl gels (BioRad) using equal amounts of protein from 
each sample. Protein were detected with antibodies targeting β-actin (R-22; Santa Cruz 
Biotechnology, Inc., Dallas, TX), α1(VI) (H-200; Santa Cruz), and decorin (H80; Santa 
Cruz). For decorin detection, blots were incubated with 1 U/mL chondroitinase ABC 
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from proteus vulgaris to digest dermatan-sulfate GAG chains from the decorin core 
protein (C2905, Sigma-Aldrich) for three hours and washed with DPBS before blocking. 
Positive controls of CCD-1064Sk Cell Lysate (Santa Cruz) for β-actin and α1(VI), and 
293 Lysate (Santa Cruz) for DCN were run simultaneously to ensure valid detection. 
Semi-quantitative analysis was performed using ImageJ to determine band intensities. 
Protein expression levels are shown relative to non-infected cells ±SEM.  
4.2.8 Immunofluorescence 
For immunofluorescence visualization, at each time point, alginate beads were 
sequentially fixed overnight in a 4% paraformaldehyde (PFA), .05M sodium cacodylate 
solution, equilibrated in 30% sucrose, embedded in Tissue-Tek O.C.T. compound 
(Sakura, Torrance, CA), and frozen and maintained at -80°C until use. Frozen sections 
(24 µm) were created using an HM550 series cryostat (Richard Allen Scientific, 
Kalamazoo, MI) and placed on gelatin-coated slides (Electron Microscopy Services, 
Hatfield, PA). For type VI collagen detection, sections were labeled with a rabbit IgG 
anti-human type VI collagen primary antibody (H-200; Santa Cruz). For decorin imaging, 
sections were incubated with 1 U/mL chondroitinase ABC for two hours and washed 
with DPBS before blocking. Sections were then labeled with a rabbit IgG anti-human 
decorin primary antibody (H80; Santa Cruz). Sections were visualized with biotinylated 
anti-rabbit IgG secondary antibodies and Texas red-labeled streptavadin 
(Labvision/Thermo Fisher Scientific, Kalamazoo, MI) and counterstained with DAPI. 
Fluorescence images were taken at 400x magnification with a Nipkow (spinning) disk-
equipped Olympus IX81 microscope.  
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4.2.9 Cellular Deformation  
For aspect ratio measurements under static compression, cells were isolated and re-
embedded in new hydrogel constructs, to remove changing alginate bead properties, with 
their PCMs intact as previously described (22). After cells were released from alginate 
using sodium citrate and EDTA, they were incubated with CMFDA to stain cell 
cytoplasm, 6-Carboxy-X-Rhodamine (6-ROX; Invitrogen) to stain non-specifically for 
the PCM, and counterstained with DAPI. Stained cells were then resuspended in 2% 
(w/v) alginate and pipetted into a 6mm x 6mm x10mm mold with a 10 µm porous 
membrane and Whatman thick blot paper (Biorad) paper attached to the top and bottom 
faces. The molds were immersed in 102mM CaCl2 for two hours to cure (92). After 
curing, constructs were placed into a custom made micrometer-controlled deformation 
device (22) and imaged at 0%, 10%, and 20% uni-axial bulk strain. Fluorescence images 
were acquired at 400x magnification. Major and minor cell diameters (fig. 4.1) as well as 
the stained PCM (PCM+Cell) diameters were measured using Image J (NIH) and used to 
calculate aspect ratios (AR= minor cell diameter/ major cell diameter). Normalized ARs 
(NAR) were calculated at each strain for each sample’s population of average deformed 




Fig. 4.1: Representative images of aspect ratio analysis under static applied strain. (A) The cell is 
stained with CMFDA (green), the PCM stained with 6ROX (red), and nuclei are stained with 
DAPI (blue). A yellow ellipse is shown around the cell and a blue ellipse is shown around the 
PCM to indicate how the major and minor diameters of the cell and the PCM+Cell were obtained. 
Scale bars indicate 20 μm. (B) PCM+Cell of CM-hMSCs, shColVI- and shDcn- transduced cells 
at day 14 under static applied strain of 0%, 10% and 20%. Cells are stained as previously 
described. The white arrows indicate the direction of applied compression. Scale bars indicate 20 
μm. 
4.2.10 Statistical Analysis 
Statistical analyses for cell viability, gene expression, western blotting and aspect ratios 
were performed using one-way ANOVA. Tukey's HSD post hoc tests were performed for 
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pairwise comparisons. All computations were performed using JMP7 (Cary, NC) with 
statistical significance set to α<0.05 or α<0.01 as indicated in results.  
4.3 Results 
4.3.1 Lentiviral vectors can induce efficient shRNA-mediated RNAi in hMSCs 
Initial screening was conducted on hMSC monolayers to identify optimal shRNA 
constructs to use for subsequent experiments. Because each shRNA sequence was 
designed to target different locations along the mRNA strand, variation in knockdown 
due to mRNA folding was expected. We found that the shColVI D construct (n=2) was 
most effective in knocking down col6a1 transcript levels, resulting in decreases of up to 
45% relative to non-infected hMSCs in monolayer over 14 days (fig. 4.2). The shDcn F 
construct induced the greatest knockdown of dcn expression, with up to 91% silencing 
over 14 days (n=2). Other constructs were less effective in inducing RNAi and were, 
therefore, excluded from subsequent experiments. 
 
Fig. 4.2:  Optimization of shColVI (A-E) and shDcn (A-F) to select the most efficient virus in 
knockdown target genes. (A) Col6a1 and (B) dcn relative gene expression as assessed by qRT-





) ± half of the range. 
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Based on the screen, we performed experiments using blasticidin selection, to 
eliminate any non-transduced cells, and assessed gene silencing in hMSCs with shColVI 
D and shDcn F constructs (hereafter labeled shColVI and shDcn, respectively). The pure 
population of shColVI-transduced cells exhibited col6a1 expression that was 
significantly decreased by 67% at day 4 (p<0.01, n≥2) and remained significantly 
depressed through 14 days (p<0.01, n≥2) (fig. 4.3). Construct shDcn achieved a 
significant 89% knockdown of dcn expression at day 1 and maintained this diminished 
level over the entire 14 days (p<0.01 for all time points, n≥2). 
 
Fig.4.3: Targeted knockdown of genes is improved with blasticidin selection in shRNA 
transduced cells at MOI (1). (A) Col6a1 and (B) dcn relative gene expression as assessed by 
qRT-PCR relative to non-infected hMSCs cultured in parallel. Data are shown as average values 




) ± half the range (*p<0.05, 
**p<0.01, ***p<0.001; n≥2). Blasticidin selection caused a slight decrease in col6a1 and dcn 
expression when non-transduced cells were removed.  
4.3.2 Gene silencing of PCM proteins does not affect chondrogenic differentiation 
As in our previous studies (22), we used alginate bead culture of hMSCs in TGF-β3-
supplemented chondrogenic induction media as a model system to study PCM formation 
during differentiation. To validate this approach for transduced cells, we verified 
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knockdown of the target genes, quantified cell viability, and confirmed chondrogenic 
gene expression. 
 
Fig.4.4: Knockdown of target genes and protein in samples cultured in CM. (A) Col6a1 and dcn 
relative gene expression as assessed by qRT-PCR (n≥3) (*p<0.05, **p<0.01 to non-infected and 







) ± half the range. (B) ColVI and DCN protein expression as 
analyzed by western blotting (D7, n=2; D14, n=2; D28, n=4) in GFP and shColVI groups relative 
to non-infected CM-hMSCs at corresponding time points. Relative protein expression was 
calculated as the ratio of the shRNA-transduced cells (target protein/ β-actin) to non-infected 
CM-hMSCs (target protein/ β-actin). Data are represented as mean ±SEM. (C) Representative 
western blotting at day 14 for α1(VI), DCN, and β-actin in non-infected CM-hMSCs, and GFP-, 
shColVI-, and shDcn-transduced cells. Positive controls (+) were run in parallel.  
Significant target gene knockdown was achieved for both shRNA constructs, as 
assessed by qRT-PCR, relative to controls of non-infected hMSCs and of a lentivirus 
transduced GFP expression cassette (Fig. 4.4A). For shColVI-transduced cells, col61a1 
knockdown remained statistically significant through 14 days but gradually diminished 
toward control levels by day 28 (Fig. 4.4A. day 7: 0.183±0.140, p<0.01; day 14: 
0.549±0.200, p<0.05; day 28: 0.740±0.406). For shDcn-transduced cells, dcn knockdown 
was statistically significant at 7 and 28 days (Fig. 4.4A. day 7: 0.253±0.228, p<0.05; day 
14: 0.769±0.575; day 28: 0.574±0.161, p<0.01) but not at 14 days. Western blots 
demonstrated that protein levels mirrored the temporal variations we observed for 
transcript levels (Fig. 4.4B and 4.4C). Cells transduced with their respective silencing 
constructs produced less α1(VI) at day 7 and day 14, and less DCN at days 7 and 28.  
To ensure viral treatment did not affect viability during the experiment, live-dead 
analysis was performed at 7, 14 and 28 days after hMSCs were embedded in alginate. 
Cells in all experimental groups maintained greater than 50% viability through the 28 
days. There was no significant difference between non-infected and infected cells; 




Fig. 4.5: Quantification of viability of alginate beads during chondrogenic culture using live-
dead imaging and ImageJ particle analysis. Data shown is %live (green) cells of total cells 
counted ± SEM (**p<0.05 from non-infected chondrogenic-hMSCS; +p<0.05 from the previous 
time point, n≥25). 
To determine whether viral transduction or knockdown of col6a1 and dcn might 
disrupt chondrogenesis, we analyzed acan and sox9 expression in non-infected and GFP-, 
shColVI- or shDcn- transduced cells. Previous work has shown that hMSCs cultured in 
alginate hydrogels in GM exhibit some features of chondrogenesis, with pericellular 
deposition of type VI collagen during the first 7 days of culture, but only with TGF-β3 
supplementation did chondrogenesis progress fully (22). Higher transcript levels were 
measured for both chondrogenic markers across all groups when cultured in CM at all 
time points relative to corresponding transduced cells cultured in GM (Fig. 4.6A and 
4.6B). Differences were statistically significant only at particular time points, likely due 
to fluctuating levels of gene expression during differentiation. There was no significant 
difference between non-infected controls and knockdown samples at any time point for 
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sox9 expression. These data indicate that transduction with the silencing cassette did not 
affect the ability of hMSCs to undergo chondrogenic differentiation.  
 
Fig. 4.6. Chondrogenic gene expression in control and knockdown cells. (A) Gene expression for 
acan and (B) sox9 in non-infected, and GFP-, shColVI- and shDcn- transduced hMSCs in 
alginate bead culture (n=3) .All data represent CM relative to their same infection condition 
cultured in GM at 7, 14, and 28 days (e.g ΔΔCt acan,D7 = ΔCtacan,CM,D7 – ΔCt acan,GM,D7) (*p<0.05 CM 
culture relative to same condition same time point in GM; +p<0.05, relative to CM-hMSCs at 
same time point; #p<0.05, relative to CM-GFP hMSCs at same time point; n≥3). Data are shown 




) ± half the 
range. 
4.3.3 Knockdown of col6a1 and dcn alter PCM structure and gene regulation 
The organization of the pericellular matrix is temporally dependent on its composition. 
DCN is a primary modulator of ColVI network assembly as well as a connector to type II 
collagen and aggrecan (59,82,87). Targeted subtraction of ColVI and DCN was expected 




ColVI and DCN deposition during chondrogenesis fully enveloped the non-infected 
and GFP-transduced cells (Fig. 4.7A and 4.7B). In non- and GFP-infected cells, DCN 
was visualized in concentrated pockets directly surrounding the cell membrane, with 
diffuse staining extending away from the cell mainly at day 7 and becoming more tightly 
gathered by day 28 (Fig. 4.7B as denoted by yellow arrows). This is consistent with the 
notion that DCN binds proteins within the PCM to form a fully developed network, 
controlling protein spacing with its attached GAG chain. 
 
Fig. 4.7: Confocal microscopy visualization of ColVI and DCN.  (A) ColVI (green) 
immunofluorescence visualization within the PCM of non-infected, and GFP-, shColVI-, and 
shDcn-transduced hMSCs cultured in alginate beads in CM at 7, 14, and 28 days. Cell nuclei are 
stained with DAPI (blue). Red arrows point to punctate ColVI staining. All images were 
standardized to similar pixel intensity ranges for valid comparisons. Negative controls without 
primary or secondary labeling showed no ColVI staining (data not shown). Scale bar indicates 
20μm. (B) Equivalent data for DCN (red) immunofluorescence visualization. Yellow arrows 
point to concentrated clusters of DCN around the cell membrane. Negative controls without 




Knocking down ColVI resulted in lower acan, bgn, and dcn levels during the first 14 
days of chondrogenesis relative to non-infected and GFP-transduced cells (Fig. 4.6A, 8A 
and 8B). This difference was diminished by 28 days. Visualization of DCN surrounding 
shColVI cells did not reflect the decreased transcription, showing similar fluorescence to 
control cells. Although ColVI knockdown affected dcn expression, DCN knockdown did 
not affect col6a1 levels (Fig. 8C) but did alter its assembly. ColVI staining appeared to 
be membrane-bound and punctate, suggesting that DCN deficiency prevents ColVI from 
forming a continuous microfibrillar layer surrounding the cell (Fig. 7A as denoted by red 
arrows). This punctate staining was maintained over the course of the 28 day experiment. 
DCN knockdown also affected the expression of other PCM proteins, leading to 
increased levels of acan, bgn, and sox9 during the first two weeks. These results indicate 
that PCM gene expression is cross-regulated, with the greatest effects being in the first 











Fig. 4.8: Pericellular gene expression in control and knockdown cells. (A) Gene expression for 
dcn, (B) bgn and (C) col6a1 in non-infected, and GFP-, shColVI- and shDcn- transduced hMSCs 
in alginate bead culture (n=3) in CM relative to the same infection condition cultured in GM at 7, 
14, and 28 days (*p<0.05, **p<0.01, CM culture relative to same condition same time point in 
GM; +p<0.05, relative to CM-hMSCs at same time point; #p<0.05, relative to CM-GFP hMSCs 





) ± half the range. 
4.3.4 Cellular and PCM stiffnesses evolve during chondrogenic differentiation 
In an effort to understand the mechanical role of the developing PCM during 
chondrogenesis, we employed an approach to quantify both the deformation of the cell 
itself (CM-hMSC) and the aggregate deformation of the cell with its PCM (PCM+Cell) 
over time in chondrogenic media (Fig. 4.9). Day 0 baseline controls represent hMSCs 
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that had been embedded in alginate constructs directly from monolayer culture, and 
consequently had no exposure to chondrogenic media. At this time point, significant 
changes in normalized aspect ratios (NARs) were observed with applied strain. Note the 
nonlinear cell stiffness at day 0; cells deform greater from 0 to 10% applied strain than 
from 10 to 20%. 
 
Fig. 4.9: Normalized aspect ratios (NAR) of cells cultured in GM or CM, and the PCM+Cell 
(CM-hMSCs). Each condition was subjected to 0%, 10% or 20% applied strain at 0, 7 and 14 
days of culture in alginate beads. Graphs show normalized aspect ratios that are overlaid with 
progressively increasing strain increments (values are not cumulative). (p<0.05 and p<0.01 with 
respect to increasing symbols. *: from previous applied strain;  +: from GM-hMSCs of same 




  ε=10% ε=20% 
 Day 0 0.893 ± 0.032  0.881 ± 0.026  
 Day 7 GM 0.920 ± 0.025 (‡) 0.909  ± 0.021 (‡‡) 
 Day 14 GM 0.950 ± 0.013 (‡‡, #) 0.902 ± 0.017 (‡) 
 Day 7 CM 0.942 ± 0.022 (‡‡) 0.911 ± 0.022 (‡‡) 
 Day 14 CM 0.965 ± 0.028 (‡‡) 0.949 ± 0.024 (‡‡, ##) 
 Day 7 PCM+Cell 0.942 ±0 .026  0.915 ± 0.028  
 Day 14 PCM+Cell 0.992 ± 0.023 (##) 0.968 ± 0.023 (#) 
Table  4.3:  Normalized AR values of each deformation and condition. (p<0.05 and p<0.01 with 
respect to increasing symbols. #: from Day 7 same strain, ‡: from D0 same strain.  N>30). 
At Day 7, GM cells (GM-hMSC) deformed less than Day 0 hMSCs, likely due to 
matrix production and assembly stimulated by 3D culture (22) which is relatively stable 
between day 7 and day 14. Because there was no discernible PCM around GM cells, 
deformations were measured for cells only. For the CM group, incomplete elaboration of 
the PCM resulted in similar deformations between the cell (CM-hMSC) and the 
PCM+Cell. 
At Day 14, GM cells exhibited significantly less deformation than at Day 7, but only 
at 10% applied strain. For CM cells, the aggregate deformation of PCM+Cell was also 
correspondingly lower than at Day 7.The most striking change was in the PCM+Cell 
deformation, which was significantly lower at both 10 and 20% applied strain. 
Interestingly, under 10% strain, the change in NAR for CM cells was higher than that for 
the PCM+Cell, but these trends are reversed at 20% applied strain. This suggests that the 
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PCM is stiffer than the cell at 10% applied strain, but that the cell becomes relatively 
stiffer at 20%.  
4.3.5 ColVI and DCN are essential for resisting cellular deformation during compression 
Our results above are consistent with previous research findings that during 
chondrogenesis hMSCs develop a mechanically functional PCM (22,84), and that a 
change in its stiffness affects cell deformation (42). As a step toward elucidating the 
functional roles of specific PCM proteins, we examined cell deformations in genetically 
engineered CM-hMSCs. Again, for baseline measurements (Day 0), we seeded 
transduced and control cells into alginate disks, and immediately subjected them to 
compressive loading. Because of the universal lack of PCM, cells exhibited significant 
changes in normalized aspect ratios with each applied strain, with no significant 
differences between groups (Fig. 4.10A). Similar nonlinearity in cell stiffness as observed 




Fig. 4.10: Normalized aspect ratios of non-infected and GFP-, shColVI-, and shDcn-transduced 
hMSCs. Each condition was subjected to 0%, 10%, and 20% applied strain at (A) day 0, (B) day 
7, and (C) day 14. Graphs show normalized aspect ratios that are overlaid with progressively 
increasing strain increments (values are not cumulative) (*p<0.05, **p<0.01 significant 
difference from GFP-transduced cells at same nominal strain; # p<0.05 significant deformation 
between 10% and 20% applied nominal strain). Data are shown as NAR ±SEM. 
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With culture, all conditions showed a greater resistance to the applied compression. 
However, the extent to which cell deformations decreased was dependent on treatment. 
Both non-infected CM-hMSCs and GFP controls exhibited the greatest decreases in cell 
deformation at both Day 7 and Day 14. This was expected since the PCM was allowed to 
develop normally in both groups. In addition, their similarity to each other confirms that 
the lentiviral infection of hMSCs does not affect cell stiffness.  
ColVI deficient cells showed the greatest deformations across all groups at both Day 
7 and Day 14, and for both magnitudes of applied strain (Fig. 4.10B and 4.10C). 
Deformation was similar between Days 7 and 14, indicating that the cell’s inability to put 
in place a mechanical barrier does not change with time. Although direct comparisons 
cannot be made, we measured greater shColVI cell deformations than GM-hMSCs in 
previous experiments (Fig. 4.9).  
Knocking down DCN resulted in interesting strain-dependent trends in cell 
deformation that were similar between Days 7 and 14 (Fig. 4.10B and 4.10C). At low 
levels of applied strain, cells deformed comparably with non-infected CM-hMSC and 
GFP controls, suggesting that the PCM was mechanically robust enough to sustain 
similar loads. Other data in our lab indicates there is no apparent evidence of any 
intracellular mechanism that alters shDcn cell stiffness (data not shown). However, once 
applied strain reached 20%, cellular resistance to deformation collapsed. We attribute this 




Overall, these results demonstrate control hMSCs that develop a full PCM are better 
able to maintain their cell-shape compared with cells with deficient PCMs. In particular, 
ColVI is required for resisting even low magnitude strains, while DCN is important in 
maintaining structural integrity at higher strains.  
4.4 Discussion 
Stem cell therapies are currently being explored for their potential in the regeneration 
of load bearing tissues, such as cartilage, due to both their pluripotency and their ability 
to maintain a basal phenotype during expansion in vitro. The PCM developed during 
chondrogenesis has been considered vital to the regulation of mechanotransduction 
events in differentiating hMSCs (57,81,93,94). Reconstruction of the PCM in isolated 
mature chondrocytes has been shown to be complex, temporally specific in composition, 
and highly dependent on protein-protein interactions within the PCM (95). Because 
chondrocyte function is closely tied to interactions with ECM proteins (96), altering the 
constituents of the PCM would likely induce cascading effects on cell-cell and cell-
matrix interactions. PCM development in chondrogenic hMSCs is expected to be even 
more complex, due to the additional changes in gene regulation associated with 
differentiation. To elucidate the functional roles of individual components in the PCM, 
we investigated the consequences of knocking down col6a1 and dcn mRNA expression 
using shRNA lentiviral vectors. 
Type VI collagen is a 125 nm long heterotrimer that consists of three different α-
chains (α1(VI), α2(VI), and α3(VI)) and self-assembles into beaded filaments and larger 
fibrillar structures (56). ColVI trimer formation occurs intracellularly before being 
secreted into the PCM for microfibrillar networking via BGN or DCN (56,58,82,83) and 
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is maintained at low levels of transcription (22,83).  DCN is a ubiquitous proteoglycan, 
consisting of a core protein with a single chondroitin sulfate (97) or dermatan sulfate (98) 
side chain. It interacts with multiple collagens to create functional bridges between the 
PCM and surrounding ECM, and is involved in controlling fibrillogenesis and growth 
factor bioavailability (3,21,28). This study shows that these two specific proteins, ColVI 
and DCN, have profound influence over PCM composition and biomechanical behavior 
surrounding hMSCs undergoing chondrogenesis. 
One of our major findings was the significant contributions of ColVI and DCN in 
cellular resistance to deformation. A developing PCM has been implicated in acting as 
both a biomechanical buffer (22,84,99) as well as a biochemical bridge (57,93,94). 
Acting as a biomechanical buffer, the PCM shields the cell from deformation which 
could be potentially detrimental while also enhancing small tissue strains for stimulation 
(16,19,22). Previous studies analyzing deformation properties of chondrocytes in alginate 
hydrogels have shown that cells under compression form oblate spheroids with a decrease 
in cell diameter along the axis of loading and an increase in transverse cell diameters 
perpendicular to that axis (100). During initial matrix deposition, we found that the 
matrix and cell share similar deformations, due to the lack of full matrix envelopment. As 
the matrix stiffens to approach and then surpass cellular stiffness, the mechanical 
properties are contributed to more equally by both components (42). With a fully 
developed matrix, at higher strains the PCM+Cell would reorganize due to hydration 
changes and spatial consolidation of collagen. Studies examining the PCM surrounding 
mechanically isolated chondrons are consistent with an initial elastic response followed 
by a transiently changing flow-dependent creep response under applied stress (5,19). The 
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mechanical behavior is dependent on PCM structure, with the elastic response governed 
by matrix deposition (42) that is highly associated with sGAG and collagen accumulation 
(84), and the viscous response governed by the osmotic and porous properties of the 
PCM network (101).  
By altering the presence of ColVI and DCN, we sought to determine their 
involvement in this composition dependent mechanical response. In mature articular 
chondrocytes, the PCM has a higher modulus than that of the cell (88). Previous studies 
in ColVI-null mice demonstrate that a PCM can be formed, but that ColVI-null 
chondrons have significantly reduced stiffness compared to wild-type chondrons (5). The 
lowered resistance to deformation we observed in ColVI knockdown cells during 
chondrogenic PCM development is consistent with this reduced stiffness. ColVI can 
therefore be considered the primary protein involved in buffering loads to differentiating 
hMSCs. 
During PCM development, it has been seen that sGAGs are important in the initial 
stages of assembly, directly impacting cellular mechanical responses to load (84). PGs 
mediate the PCM to ECM interface through interactions with types II and VI collagen 
(3,17,59,82). Cells compensated for dcn knockdown by upregulating bgn expression, 
demonstrating a regulatory effect by DCN on other PCM small leucine rich PGs (sLRPs) 
(62). BGN core protein has significant sequence homology with that of DCN, but is 
structurally distinct and possesses two (instead of one) CS/DS chains (102-104). Similar 
compensatory effects have also been seen in DCN knockout models (3,28). BGN shares 
binding sites on collagen proteins with DCN, but has a lower affinity, causing a lower 
involvement in PCM and ECM organization (3) and the extra CS/DS- side chain on BGN 
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results in a looser collagen network (28,59,62,87,105). The looser collagen spacing 
possibly contributed to the significant increases in shDcn cellular deformation at higher 
strains. This network is bound to the cell membrane through HA core protein-CD44 
interactions (98), NG2 receptors (membrane bound chondroitin sulfate PGs) or through 
direct binding to the α1β1 integrin (85). From our confocal images, the altered ColVI 
assembly in shDcn knockdown cells appeared as punctate localizations completely 
surrounding the cells at these binding sites.  
In addition to acting as a mechanical stabilizer, the PCM also aids maintenance of 
chondrocyte phenotype biochemically. Our data are in agreement with chondrogenic 
stage specific gene expression (4), with col6a1 being significantly greater in the first 
seven days of chondrogenesis in non-infected and GFP-transduced cells, which decreases 
in expression by 28 days of culture. DCN is involved in the sequestration of TGF-β3, 
FGF-2, TNF-α, PDGF, and IGF-1 (3,21,62) and has been associated with cell 
proliferation signaling (3), causing the cell to cease proliferation and enhance matrix 
synthesis. These growth factors cause PCM accumulation during chondrogenesis in a 
concentration dependent manner (11,42,97). Sequestration of growth factors immediately 
surrounding the cell allows for specifically stimulated responses, being released 
mechanically or enzymatically from their associated PG for presentation to the cell 
membrane. Sox9, comp and  HAPLN1 expression levels have shown to reach a peak by 
12 days of culture associated with high levels of matrix assembly and metabolism (4). 
The large overexpression of sox9 in shDcn cells at day 14 could be due to the lack of 
regulation and continuous bioavailability of TGF-β3 to the cell.  
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Full PCM formation occurs within the first two weeks of TGF-β3 stimulation in vitro, 
which parallels the upregulation of acan and bgn expression during the first 14 days, and 
then steadily matures as acan returns to control levels. PCM retention has been shown to 
be mediated through interactions between CD44 and hyaluronic acid, which lay a 
foundation for aggrecan accumulation and affects PCM volume and shape (19,98). 
Hyaluronan is critical for maintenance of the pericellular environment surrounding 
chondrocytes (96), interacting with type II collagen, aggrecan and link protein. The 
observed higher acan upregulation in shDcn cells could aid in matrix protein retention 
and reorganization, causing large changes in the mechanical composition of the PCM, 
affecting cellular metabolism. shColVI cells showed an opposite trend of acan and bgn 
expression, with lower expression levels during the first 14 days of culture than all other 
samples.  
4.5 Conclusion 
To our knowledge, this study is the first to elucidate the functional significance of 
DCN in the PCM. Furthermore, we extend our previous work (22) by demonstrating that 
ColVI is crucial for the biomechanical integrity of the PCM in chondrogenic hMSCs at 
all stages of differentiation. The use of shRNA expressing lentiviral vectors allows stable 
production of siRNAs by the cell (74). This approach has enabled us to characterize how 
specific PCM proteins govern the micromechanical environment of differentiating 
hMSCs over time. Although further studies are required to elucidate the downstream 
effects on mechanotransduction events, signaling cascades, and load-induced behaviors, 
our results provide some immediate insight into strategies that can be used to engineer 
specific microenvironments for eliciting desired cellular responses.  
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Chapter 5: Determining ColVI and DCN’s role in 





Mechanotransduction events during chondrogenesis determine how differentiating 
human mesenchymal stem cells (hMSCs) will develop into tissues. Understanding the 
molecular underpinnings of these events is necessary for providing the desired signaling 
to cells in tissue engineered constructs of compressive load-bearing tissues such as 
articular cartilage (48). Native cartilage tissue is composed of a complex network of 
interconnected collagens, proteoglycans, and non-collagenous proteins which are 
organized to withstand the applied compression, tension, and shear during physiologic 
loading (17-19,21). This highly organized matrix is maintained through a balance of 
anabolic and catabolic factors caused by mechanical stimulation (16,76,106,107). Under 
dynamic culture, chondrocytes increase synthesis of types I and II collagen, aggrecan and 
versican (16,39,108-111). It has been shown that the pericellular matrix (PCM) directly 
surrounding chondrocytes plays a central role in governing mechanobiology (13,94). 
Similarly, the developing PCM in chondrogenically differentiating hMSCs is likely to be 
involved in many of these cellular signaling events,  
 
2
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and may regulate mechanoresponsiveness based on its evolving structure and function.  
In native chondrons, the PCM has a distinct composition of type VI collagen (ColVI) 
(5,19,22,57,60), fibronectin and hyaluronan (21,84), and proteoglycans such as aggrecan, 
decorin (DCN), biglycan (17,20,82), and perlecan  (68). We have previously shown that 
in chondrogenically differentiating hMSCs, ColVI and DCN are similarly expressed and 
completely envelop the cell over the course of two weeks (22). Activation of signaling 
molecules during this two week differentiation process is highly important, with 
expression peaks of members of the transforming growth factor β superfamily, fibroblast 
growth factor-2 (FGF-2) (68), cartilage oligomeric matrix protein (COMP) (107) and 
transcription factor Sox9 (112) as well as expression of various integrins at the cell 
surface (67). Since, the time dependent aggregation of matrix proteins surrounding the 
cell determines how the cell interacts with its microenvironment, it is possible that PCM 
growth is linked to the robustness of the cell’s response to applied stimulation. 
The PCM’s control over mechanotransduction events occurs not only through its 
compositionally specific matrix, but also through its biomechanical properties (107). 
We’ve previously shown that by altering the cell’s ability to form a fully developed PCM 
through shRNA lentiviral knockdown of ColVI and DCN, chondrogenic hMSCs show 
varying abilities to withstand applied static compression in hydrogels (113). The increase 
in deformation we witnessed could shift mechanosignaling through changing the cell’s 
cytoskeletal response.  Differentiating hMSCs have a highly dynamic cytoskeleton that is 
directly dependent on the evolving ECM (112,114) and is more pronounced in areas of 
intensive loading (112,115), having higher amounts of actin microfilaments (AMFs), 
vimentin intermediate filaments (VIFs), and microtubules (MTs). These proteins are 
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involved in maintaining the cell’s structural integrity (114) during loading as well as 
transferring the loads to the nucleus to regulate gene expression (70,71,112,115,116) . 
Disruption of these components leads to drastic changes in chondrocyte phenotype 
through shifts in sGAG and collagen synthesis and transcription (72,117,118). The 
transmission of mechanical stimulation to the nucleus via the cytoskeleton is a physical 
pathway for mechanotransduction (71).  
The intertwined relationship between matrix and cytoskeletal contributions to the 
mechanotransduction process is difficult to dissect. The goal of this study was to 
determine how knockdown of ColVI and DCN in chondrogenic hMSCs affects the 
dynamic response of the cytoskeleton following a short duration load and then further 
examine changes in gene expression. Understanding how extracellular proteins are 
involved in cellular homeostasis and metabolic response can further regenerative 
medicine by revealing one aspect to control these reactions. We found that ColVI and 
DCN knockdown affected AMF and VIF dynamics respectively and bmp6, comp, and 
fgf2 were all sensitive to loading during chondrogenic PCM development. These results 
demonstrate how compositionally changing the PCM during differentiation using 




5.2 Materials and Methods 
For this study we designed experiments to investigate how chondrogenic stem cell 
mechanobiology is affected by distinct PCM structure and composition.  Five cell 
populations were examined: 
 wild-type non-infected growth media controls (GM) 
 wild-type non-infected chondrogenic hMSCs (CM) 
 GFP lentivirus-transduced chondrogenic hMSCs (GFP) 
 shColVI lentivirus-transduced chondrogenic hMSCs (shColVI) 
 shDcn lentivirus-transduced chondrogenic hMSCs (shDcn) 
To enable progressive accumulation of PCM, cells were pre-cultured in alginate 
beads for 7 or 14 days, at which point cells were recovered from alginate beads and re-
embedded in newly formed alginate disk constructs.  Disk constructs were then 
transiently subjected to one hour of cyclic dynamic loading, with free-swelling constructs 
as a reference group.  Cell functional outcomes were assessed at various times (0hr, 1hr, 
and 4hr) after cessation of loading. 
5.2.1 shColVI and shDcn Lentiviral Prep 
Sequences for shRNA targeting either col6a1 or dcn were designed using RNAi 
codex from either human col6a1 (Gen Bank: NM_001848) or human dcn (GenBank: 
NM_001920) mRNA as previously described (Twomey, 2014). Briefly, shRNA lentiviral 
vectors were created using the BLOCK-iT U6 RNAi Entry Vector Kit and the BLOCK-
iT Lentiviral RNAi Expression System (Invitrogen, Carlsbad, CA) consisting of 21 nt 
 62 
 
shRNA sequences complimentary for col6a1 or dcn (Table 5.1) and a  blasticidin 
resistance gene with a U6 promoter and a Pol III termination sequence.  
 








Table 5.1: Sense and anti-sense hairpin sequences for shColVI and shDcn. 
Replication-deficient lentiviruses were created using 293FT cells, Lipofectamine 
2000 and a manufacturer-supplied packaging mix (Invitrogen). A lentiviral expression 
vector containing the gene for GFP was prepared in parallel using the Vivid Colors 
pLenti6.2-GW/EmGFP kit (Invitrogen) to serve as a lentiviral control. Supernatant 
containing the viral vectors were stored at -80°C until used experimentally.  
5.2.2 Cell culture and lentiviral transduction 
hMSCs were purchased from Lonza and expanded in monolayer in a basal non-
differentiation growth media (GM) consisting of high glucose DMEM (HG-DMEM) 
(Gibco/Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) 
(Gibco), 100U/mL penicillin/streptomycin (Gibco), 1% MEM non-essential amino acids 
(Gibco), and 4mM L-Glutamine (Invitrogen). Cells were expanded in monolayer at 37°C 
with 5% CO2 with media changes three times per week and used for experiments as 
passage 4 or 5.  
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Experimental hMSCs were infected in monolayer at a multiplicity of infection (MOI) 
of 1 with shColVI, shDcn, or GFP-expression (control) lentiviral vector in the presence 
of 6µg/mL Polybrene (Sigma) to aid in transduction efficiency for 24 hours. MOI was 
determined through a Quant-IT PicoGreen (Invitrogen) titer assay. After viral incubation, 
cells were cultured for 24 hours in GM, followed by 24 hours of GM containing 12 
µg/mL of blasticidin to select for a pure population of transduced cells as previously 
described (113).  
After selection, cells were lifted from monolayer using 0.25% trypsin-EDTA (Gibco), 
centrifuged at 600xg for 5 minutes before being re-suspended in a 2% (w/v) alginate 
solution (Research Products International, Mount Prospect, IL) at a concentration of 2.0 x 
10
6
 cells/mL. Alginate beads were formed by expelling alginate from a 22 gauge needle 
into a 102mM CaCl2 bath. Beads were cured for 10 minutes, followed by a wash in PBS 
containing calcium and magnesium. Alginate-cell beads were cultured in chondrogenic 
induction media (CM) containing HG-DMEM, ITS Universal Culture Supplement 
Premix (BD Biosciences, San Jose, CA), 10nM dexamethasone, 50µg/mL L-ascorbic 
acid (Sigma), 40 µg/mL L-Proline (Sigma), 100U/mL penicillin/streptomycin, 1mM 
sodium pyruvate, 0.584 g/mL L-glutamine, and 10ng/mL TGF-β3 (Lonza). Non-infected 
hMSC controls were cultured in alginate beads in either CM or GM in parallel.  
Differentiation of hMSCs and PCM accumulation occurred over 7 or 14 days of alginate 
bead culture at 37°C with 5% CO2 with media changes three times per week. At these 
time points, a few beads per condition were collected for ColVI and DCN protein 
visualization.  Other beads were used to recover cells with their PCMs intact from the 
alginate for dynamic loading experiments.   
 64 
 
5.2.3 Application of Dynamic Loading 
Cells were recovered from alginate at 7 or 14 days and re-embedded in new alginate 
hydrogel constructs in order to ensure the material properties of the alginate would be 
identical across 7 and 14 day pre-culture groups (22). To recover cells, beads were 
immersed in a 100mM sodium citrate, 30mM EDTA solution, centrifuged, and 
resuspended in 2% (w/v) alginate solution. The cell suspension was pipetted into 
cylindrical disk-shaped aluminum molds (Ø6mm x 3mm in height) at a concentration of 
10
6
 cells/mL with a 5 µm porous membrane and Whatman filter paper attached to the top 
and bottom faces of the molds (Fig. 5.1) (92). Molds were immersed in a 102 mM CaCl2 
bath for 90 minutes to ensure complete alginate curing.  
 
Fig. 5.1: (A) Aluminum molds with Ø6 mm x 3 mm well, (B) which are loaded with cell-seeded 
2% (w/v) alginate solution, (C) compressed between two aluminum plates with Whatman and 
filter paper to allow CaCl2 curing. (D) Once disks were cured, they were moved to a Ø60 mm 
petri-dish containing a 1.5 mm thick agarose mold with Ø8 mm diameter wells punched out to 
maintain local position and unconfined conditions and equilibrated in warmed media for thirty 
minutes.  
Alginate constructs were then removed from the molds, washed twice with PBS 
containing magnesium and calcium, and then equilibrated at free-swelling conditions in 
their corresponding culture media for thirty minutes prior to applied dynamic loading. A 




Fig. 5.2: Dynamic loading set-up. (A) Schematic of Ø60mm petri-dishes containing a 1.5mm 
thick agarose mold with Ø8mm diameter wells to maintain alginate disk position. Ø6mm x 3mm 
thick alginate disks were loaded in warmed media. (B) The Ø60 mm diameter petri dishes were 
fixed within a water bath maintained at 37°C. A Ø40mm polysulfone plunger was attached to a 
200g load cell. Displacement controlled sinusoidal strain was applied using an LM-1, 
Bose/Electroforce materials testing machine. (C) Force and displacement feedback was collected 
over the hour of transient load. (D) Schematic of culture period, loading duration, and harvest 
times.  
To maintain position and unconfined conditions during loading, Ø8 mm wells were 
punched out of a 1.5mm thick agarose gel cast in Ø60 mm petri dishes, and one alginate 
construct was placed into each well (fig. 5.2A). Petri-dishes were fixed within a water-
bath maintained at 37°C. The compression fixture consisted of an impermeable 
polystyrene Ø40 mm compression plunger mounted to a materials testing system as 
shown in fig. 5.2A and 1B (LM-1, Bose/Electroforce, Eden Prairie, MN). Alginate 
constructs were immersed in serum-free media during loading. After an initial 2g tare 
load was applied to ensure alginate-platen contact, sinusoidal unconfined axial 
compressive loading was applied under displacement control at 0.1Hz from 0-10% strain. 
A representative plot of the loading configuration can be seen in fig. 5.2C. Dynamic 
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loading was applied for an hour, after which samples were removed from the fixture. 
Non-loaded free-swelling (FS) disks were maintained in similar agarose-petri dish 
conditions within 37°C, 5% CO2 for the hour of loading. Following loading, disks were 
either harvested immediately, or returned to the incubator and maintained at 37°C and 5% 
CO2 until harvests at one or four hours post loading for viability, gene expression, and 
immunofluorescence (fig. 5.2D). 
5.2.4 Viability 
We quantified cell viability following alginate re-embedding and loading.  Disks were 
collected from free-swelling conditions or immediately following applied load (0 hr) and 
centrally cut to obtain and stained with 5-chloromethylfluorescein diacetate (CMFDA; 
Invitrogen) and ethidium homodimer-1 (EthD-1; Invitrogen) and counterstained with 
4',6-diamidino-2-phenylindole (DAPI; Invitrogen). Ten confocal fluorescence image 
stacks were taken at 5 µm slices to total 30 µm of depth from the cut face of the bead 
were taken at 100x magnification with a Nipkow (spinning) disk-equipped Olympus 
IX81 microscope. Viability was assessed using channel separation and threshold particle 
analysis using ImageJ (NIH) to count the number of green and red only cells. All results 
are expressed as a percentage of total cells that are viable (green only). 
5.2.5 Immunofluorescence visualization of ColVI, DCN, and cytoskeleton proteins 
Alginate beads were collected at day 7 and 14 of culture and fixed in a 4% 
paraformaldehyde (PFA), 0.05M sodium cacodylate solution overnight. Beads were 
equilibrated in 30% sucrose, embedded in Tissue-Tek O.C.T. compound (Sakura, 
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Torrance, CA), and then frozen and maintained at -80°C until used for cryosectioning 
(HM550, Richard Allen Scientific, Kalamazoo, MI).  
For ColVI and DCN immunofluorescence, 24 µm cryosections were placed on 
polysilane-coated slides (Electron Microscopy Services, Hatfield, PA), then blocked with 
normal goat serum (Vector Lab), prior to primary antibody labeling. For ColVI 
visualization, sections were labeled with a rabbit IgG anti-human type VI collagen 
primary antibody (H-200; Santa Cruz Biotechnology) as previously described (113). To 
visualize decorin, sections were incubated with 1 U/mL chondroitinase ABC for two 
hours and washed with DPBS before blocking. Sections were then labeled with a rabbit 
IgG anti-human decorin primary antibody (H80; Santa Cruz Biotechnology).  
For visualization of cytoskeletal changes, 30 µm cryosections were treated with 0.1% 
Triton-X to permeabilize cell membranes prior to blocking and primary antibody 
incubation. Sections were labeled either with a rabbit polyclonal IgG anti- human actin 
primary antibody (H-300; Santa Cruz Biotechnology), a rabbit monoclonal IgG anti-
human vimentin primary antibody (SP20; Thermo Scientific), a mouse monoclonal IgG3 
anti- human β-tubulin primary antibody (G-8; Santa Cruz Biotechnology), or a mouse 
monoclonal IgG1 anti-human vinculin primary antibody (7F9; Santa Cruz 
Biotechnology).  
All sections were visualized with biotinylated anti-rabbit or anti-mouse IgG 
secondary antibodies, Texas red-labeled streptavadin (Labvision/Thermo Fisher 
Scientific, Kalamazoo, MI), and DAPI. Confocal image stacks (1.25 µm slices) were 
taken at 400x magnification with a Nipkow (spinning) disk-equipped Olympus IX81 
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microscope. All proteins were imaged using identical exposure times for repeatability. 
Projection images with created from the image stacks for image analysis.  
5.2.6 Fluorescence Intensity Measurements 
Fluorescence intensity of the labeled proteins was quantified using ImageJ (119). 
Cells within each image were manually traced along their membrane perimeter and their 
corrected total cell fluorescence intensity measurements per cellular area were calculated 
using:  
CTCF (Corrected Total Cell Fluorescence)/ Cellular Area = (Integrated 
Density- (Area of selected cell x mean fluorescence of background 
reading)) / Cellular Area (microns
2
) 
All data are shown as the average CTCF/area ±SEM (N≥100 cells per harvest and culture 
condition).  
5.2.7 Gene Expression 
To analyze the effect of type VI collagen and decorin knockdown on cell gene 
expression to transient mechanical loading, qRT-PCR was performed either immediately 
following, one hour after, or four hours after termination of cyclic loading. Free-swelling 
samples were harvested in parallel following one hour of free-swelling. At the 
appropriate time points, cells were released from their alginate scaffold as previously 
described using a 100mM sodium citrate, 30mM EDTA solution, spun down and re-
suspended in a buffer solution containing β-Mercaptoethanol (Fisher Scientific, 
Pittsburgh, PA) before flash freezing. Total RNA was isolated (RNeasy Micro, Qiagen, 
CA) and reverse transcribed. Gene expression was analyzed using qRT-PCR (MyiQ 
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System, BioRad, CA) with primers designed for human genes (Table 5.2) using Primer3 
software (web ref. 2). Gene expression levels for 18s, acan, bgn, bmp6, col1a1, col6a1, 
comp, dcn, fgf2, rhoa1, runx2, sox9, and vim were quantitatively assessed as previously 
described (89,113).  All primer amplification efficiencies were determined using linear 




























































Table 5.2: Sequences of Primers used for real time RT-PCR. 
Expression levels were analyzed using the ΔΔCt method. Cycle threshold (Ct) values 
were averaged and ΔCt was calculated by subtracting the average Ct values of GAPDH 
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from those of the gene of interest (ΔCtcol6a1 = Ctcol6a1 – CtGAPDH) as previously described 
(Twomey, 2014). The ΔΔCt for each gene of interest was determined by subtracting the 
ΔCt of the growth media free-swelling control at day 7 from the experimental ΔCt at each 
time point (i.e. ΔΔCtcol6a1,shColVI, D7@4hrs = (ΔCtcol6a1,shColVI, D7@4hrs – ΔCtcol6a1,GM, D7@FS)). 
Free swelling growth media samples at day 7 were considered the experimental controls, 
with a minimal PCM developed during the initial 7 days of culture. Relative gene 
expression levels (fold difference) were computed through the exponential relation 2
-ΔΔCt
  





) ± range. 
5.2.8 Statistical Analysis 
Statistical analyses for cell viability, gene expression, and CTCF/area measurements 
were performed using one-way ANOVA. Tukey's HSD post hoc tests were performed for 
pairwise comparisons. All computations were performed using JMP7 (Cary, NC) with 
statistical significance set to α<0.05 as indicated in results.  
5.3 Results 
5.3.1 ShColVI and shDcn lentiviral vectors caused significant targeted knockdown 
Significant knockdown of col6a1 and dcn was achieved by shColVI and shDcn 
successively over the 14 days of alginate culture (fig. 5.3). ShColVI maintained between 
40-65% knockdown over the 14 days compared to non-infected chondrogenic hMSCs 
(fig 5.3A: col6a1 gene expression: shColVI (D7: 0.345± 0.090; D14: 0.555±0.143) 
versus GFP (D7: 0.815± 0.167; D14: 1.290±0.270). ShDcn also maintained 63-73% 
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knockdown (fig 5.3B: dcn gene expression (shDcn (D7: 0.365±0.346; D14: 0.267±0.160) 
versus GFP (D7: 1.199±0.609; D14: 2.310±1.350)).  Decreased accumulation of ColVI 
and DCN in the PCM was confirmed using immunofluorescence visualization (fig. 5.3C 
and 5.3D). Type VI collagen developed a full PCM completely enveloping the cell by 
day 14, with shColVI samples lacking ColVI labeling. DCN staining was robust within a 
well-developed PCM during the 14 days of chondrogenic culture, with shDcn inhibiting 






Fig. 5.3: Knockdown of target genes and protein in samples cultured in CM. Relative (A) col6a1 
and (B) dcn gene expression (fold difference) at day 7 and day 14, as assessed by qRT-PCR of 
GFP-, shColVI-, and shDcn-transduced cells relative to chondrogenic non-infected hMSCs (#: 
p<0.05 to chondrogenic non-infected and GFP-transduced cells; n≥3). Data are shown as average 




) ± half of the range. 
Significant knockdown was achieved by shColVI samples at day 7 and 14 and shDcn achieved 
significant knockdown at day 14, which maintained significant knockdown during transient load. 
(C) Immunofluorescence visualization of ColVI and (D) DCN proteins surrounding chondrogenic 
cells. Non-infected and GFP-transduced cells cultured in chondrogenic media developed a type 
VI collagen PCM surrounding cells which was inhibited in shColVI cells. DCN staining showed 




5.3.2 Dynamic loading did not reduce viability 
Cell viability was found to be unaffected by dynamic loading in any condition at both 
time points. Viability did significantly decrease in shColVI and shDcn samples at D14 
compared to chondrogenic hMSCs, but were still 60% viable during dynamic loading.  
5.3.3 ColVI and DCN differentially controlled cytoskeletal organization in response to 
load 
The involvement of the cytoskeleton in mechanosignaling has been well established 
in both chondrocytes and chondrogenic hMSCs. For differentiating hMSCs, the 
dynamically changing PCM may alter the role of the cytoskeleton in cellular 
mechanobiology. To investigate the mechanoregulation of cytoskeletal elements in 
differentiating and engineered stem cell populations, we quantified relative changes in 
fluorescence intensity levels of g-actin (AMF), vimentin (VIF), β-tubulin (MT), and 
vinculin, at various time points after loading. 
Actin microfilaments 
Load-induced changes in AMF intensity levels differed between pre-culture 
durations, and across the five cell treatment groups (fig. 5.4C). At day 7, FS samples 
exhibited significantly lower values in GM cultures than the four FS chondrogenic 
cultures (fig. 5.4A and 5.4C). Cyclic compression of alginate constructs resulted in small, 
and in some instances statistically significant, changes in AMF intensity immediately 
after loading.  
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Day 14 AMF intensity data yielded more identifiable trends. For FS samples, again g-
actin fluorescence was higher in chondrogenic groups compared with GM, similar to day 
7. In fact, chondrogenic fluorescence was uniformly higher across loading groups, as 
well. Interestingly, cyclic loading resulted in transient increases in g-actin fluorescence 
immediately after loading for chondrogenic controls (non-infected and GFP) as well as 
shDcn. But this spike in AMF staining was absent in GM and shColVI cells (fig. 5.4C).  
 
Fig. 5.4: Confocal fluorescence visualization of AMFs at (A) day 7 and (B) 14 in non-infected 
GM and CM hMSCs and GFP-, shColVI-, and shDcn-transduced cells in free-swelling (FS) 
conditions and immediately following (0 hr) and four hours post load (4 hrs). Scale bars = 20 µm. 
C) Corrected total cell fluorescence per cellular area intensities for all samples at day 7 and day 
14.  *:p<0.05 from GM samples at each time point; #:p<0.05 from CM & GFP at each time point; 





Vimentin intermediate filaments 
The VIF network exhibited very different patterns from AMFs during culture and 
following load (fig. 5.5B). Vimentin staining was filamentous, with intense cortical and 
perinuclear staining, in agreement with current literature (116,117). Similar to actin, all 
chondrogenic groups possessed significantly higher intensities than GM corresponding to 
preculture and loading conditions. For GM, CM, and GFP cells, VIF intensities measured 
in FS samples were similar between Days 7 and 14 (fig. 5.5A and 5.5B). However, the 
response to loading strongly depended on pre-culture duration. Whereas cyclic 
compression induced no change or small decreases in VIF staining at Day 7, it resulted in 
progressively increasing intensities at Day 14.  
For shColVI and shDcn groups, VIF intensities in both FS and loaded samples at Day 
7 exhibited similar levels and trends as their non-infected and GFP chondrogenic 
controls. At Day 14, at which point the mechanical function of the PCM begins to differ 
significantly from wild-type (113), the baseline FS vimentin staining becomes 
significantly higher than all other FS groups. The VIF response to cyclic loading is 
correspondingly muted for shColVI and shDcn groups at Day 14, perhaps due to the 




Fig. 5.5: Confocal fluorescence visualization of VIFs at (A) day 7 and (B) 14 in non-infected GM 
and CM hMSCs and GFP-, shColVI-, and shDcn-transduced cells in free-swelling (FS) 
conditions and immediately following (0 hr) and four hours post load (4 hrs). Scale bars = 20 µm. 
C) Corrected total cell fluorescence per cellular area intensities for all samples at day 7 and day 
14.  *:p<0.05 from GM samples at each time point; #:p<0.05 from CM & GFP at each time point; 
+: p<0.05 from day 7 to day 14; A:B:C: p<0.05 between loading harvests. 
Microtubules 
Microtubules were observed to exhibit similar features in dynamics as actin and 
vimentin. For FS conditions, chondrogenic groups generally possessed higher MT 
staining intensities than the GM groups. In response to cyclic compression, non-infected 
and GFP-transduced chondrogenic hMSCs had transient, but significant increases in 
staining immediately after loading, similar to what we observed in AMF staining (fig. 
5.6C). Cyclic loading induced progressively increasing intensity levels in both Day 7 and 
Day 14 GM groups, similar to changes we observed in VIF (fig. 5.6A and 5.6B). This 
was also seen in shDcn at day 7. At day 14, shColVI and shDcn groups showed higher FS 
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intensity levels than all other FS groups and were initially unresponsive to load, but then 
decreased in intensity by four hours post load. MT staining was filamentous and localized 
cortically.  
 
Fig. 5.6: Confocal fluorescence visualization of MTs at (A) day 7 and (B) 14 in non-infected GM 
and CM hMSCs and GFP-, shColVI-, and shDcn-transduced cells in free-swelling (FS) 
conditions and immediately following (0 hr) and four hours post load (4 hrs). Scale bars = 20µm. 
C) Corrected total cell fluorescence per cellular area intensities for all samples at day 7 and day 
14.  *:p<0.05 from GM samples at each time point; #:p<0.05 from CM & GFP at each time point; 
+: p<0.05 from day 7 to day 14; A:B:C: p<0.05 between loading harvests. 
Vinculin 
At Day 7, FS vinculin staining did not appear to depend on cell treatment in contrast 
to the other cytoskeletal elements, and all staining intensities generally increased with 
pre-culture duration from 7 to 14 days (fig. 5.7A, 5.7B, and 5.7C). The non-infected, 
GFP, and shColVI groups appeared to share similar features of vinculin staining. For 
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instance, the increased staining from 7 to 14 days was much higher in these three groups, 
and staining was more diffuse throughout the cell. In contrast, the GM and shDcn groups 
possessed more punctate staining under all conditions, but notably even after loading. 
Vinculin staining localized to the cell membrane in chondrogenic samples and continued 
to concentrate at the cell membrane four hours after load. 
 
Fig. 5.7: Confocal fluorescence visualization of vinculin at (A) day 7 and (B) 14 in non-infected 
GM and CM hMSCs and GFP-, shColVI-, and shDcn-transduced cells in free-swelling (FS) 
conditions and immediately following (0 hr) and four hours post load (4 hrs). Scale bars = 20µm. 
C) Corrected total cell fluorescence per cellular area intensities for all samples at day 7 and day 
14.  *:p<0.05 from GM samples at each time point; #:p<0.05 from CM & GFP at each time point; 
+: p<0.05 from day 7 to day 14; A:B:C: p<0.05 between loading harvests. 
5.3.4 Mechanosignaling cascades initiated by ColVI and DCN 
Mechanical stimulation influences the metabolic activity of chondrocytes and 
chondrogenic hMSCs. Cells maintain their environment through this stimulation by 
 80 
 
producing a balance of anabolic and catabolic proteins (106). We have previously seen 
that the altered matrix surrounding shColVI- and shDcn- transduced hMSCs causes 
varying levels of deformation under applied constant strain, which would affect the 
signaling cascade initiated following transient loading (113). 
Mechanosignaling initiation was found to be directly controlled by amount of time in 
alginate culture which is directly related to PCM accumulation. Expression levels of fgf2 
and bmp6 showed an increasing expression level post load at both time points in all 
samples cultured in chondrogenic media (fig. 5.8A and 5.8B). In growth controls, the 
expression levels of these genes were relatively unresponsive to load. The slow response 
of these two genes to be expressed, with a small level of increase until the four hour 
harvest shows that these genes are activated further down on the signaling cascade. At 
day 14, shColVI also showed a stronger response to the mechanical loading than at day 7, 
which wasn’t seen in the other chondrogenic samples. 
 Comp expression showed no significant changes with loading in growth media or 
chondrogenic non-infected, GFP- and shColVI- transduced hMSCs, yet was responsive in 
shDcn samples at day 7. ShDcn cells exhibited a vast upregulation of comp expression in 
free-swelling samples compared to all other conditions and was unaffected by load until 
the 4 hour harvest point, where expression dropped to growth control levels. At day 14, 
this significantly higher expression was diminished in the free-swelling shDcn cells, and 
matched the chondrogenic non-infected and GFP-transduced cells, but still showed a 
difference in response to load. CM-hMSCs and GFP-hMSCs showed an increase 
immediately following load, which then dropped at 1 hour and then again increased by 4 
hours post loading. The response was more robust in chondrogenic non-infected hMSCs, 
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than its GFP-transduced counterpart. ShColVI cells showed an upregulation of comp, 





Fig. 5.8: Relative gene expression (fold difference) of day 7 (a) and day 14 (b) non-infected GM 
and CM cells and GFP-, shColVI-, and shDcn- transduced cells to free swelling GM-hMSCs at 
day 7. *:p<0.05 from GM samples at each time point; #:p<0.05 from CM & GFP at each time 




The chondrogenic and osteogenic markers of sox9 and runx2 were unaffected by 
mechanical loading at day 7 and showed a small response at day 14. The PCM proteins of 
acan, bgn, and col1a1, showed significant increases in chondrogenic samples compared 
to growth, but showed no significant changes in expression levels following loading at 
either time point. Rhoa1 expression was measured to compare against actin dynamics, 
and was seen to be unresponsive in all samples except chondrogenic non-infected and 
shColVI-transduced cells at both time points, but the gene expression trend was not 
reflected by the polymerization of g-actin staining (fig. 5.9A and 5.9B). Vim expression 
was also not significantly affected and did not match the cytoskeletal visualization (fig. 






Fig. 5.9: Relative gene expression (fold difference) of day 7 (a) and day 14 (b) non-infected GM 
and CM cells and GFP-, shColVI-, and shDcn- transduced cells to free swelling GM-hMSCs at 
day 7. *:p<0.05 from GM samples at each time point; #:p<0.05 from CM & GFP at each time 
point; +: p<0.05 from day 7 to day 14; A:B:C: p<0.05 between loading harvests. 
5.4 Discussion  
Examining the relationship between mechanical stimulation and the cell's biological 
response during chondrogenic differentiation is necessary for construct design for 
articular cartilage tissue engineering. Current studies compare cartilage tissue explants 
(115,120), isolated chondrocytes (65,71,76,121,122), and differentiating stem cells 
(18,69,83) to examine how the mechanosignaling cascade changes during matrix 
development. Most frequently, agarose or alginate hydrogel constructs are used to 
identify these responses in vitro to allow the cells to maintain their round phenotype 
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within a homogenous environment (22,63,65,66,110). These studies apply physiologic 
loading at varying points during differentiation to analyze gene expression and matrix 
accumulation (53,55,67). Our study analyzed the contribution of ColVI and DCN to 
mechanosignaling through targeted mRNA knockdown prior to chondrogenic 
differentiation and studying gene expression and cytoskeletal changes following an 
applied load. Examining the shift in mechanotransduction events at varying points of 
PCM accumulation demonstrates the temporally specific control of cell-matrix dependent 
responses.  
Mechanotransduction events are potentially controlled by cellular interactions with 
the developing matrix through α1β1 (85,107), α2β1, and α5β1 integrins (67,123), annexin 
5 (124), CD44 (98) and NG2. Integrins transmit forces from the matrix to the cell through 
focal adhesions where integrins link to the actin cortex via vinculin, activating GAG and 
collagen synthesis under dynamic compression (67). Specific integrin activation is 
dependent on the mode of physiologic loading (13,67). These actin-vinculin co-
localizations are seen in cartilage explants (115) as well as during in vitro differentiation.  
Vinculin staining was punctate in chondrogenic non-infected and GFP- and shDcn- 
transduced free-swelling samples. Following load, vinculin was spread through the 
cytoplasm in non-infected and GFP-transduced cells, mimicking g-actin distribution 
(72,115) but not in shDcn cells which remained fragmented. G-actin staining was 
consistent with literature, showing punctate and cortical localization, without stress fibers 
formation from cytoplasmic g-actin due to the round architecture of the cell from the 
alginate hydrogel (114). Punctate staining of vinculin and g-actin in growth media 
samples demonstrate that focal adhesions can be formed through mechanical stimulation 
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without a fully enveloping matrix. ShColVI samples showed a significantly higher 
intensity of the diffuse g-actin staining at day 14, which then lacked a dynamic response 
following load. These samples also showed a decrease in vinculin staining following 
load, with no concentrated aggregates. Focal adhesion creation is tied to a decrease in 
aggrecan, proteoglycan, and type II collagen synthesis (48). ShColVI samples have 
previously shown a lower expression of acan and dcn at day 14 than chondrogenic 
controls (113). The compositionally different PCM formed surrounding these cells may 
inhibit focal adhesion development through varied integrin expression, tying focal 
adhesion creation and proteoglycan gene expression into a more dependent relationship 
than previously examined, though this needs to be further explored.  
Actin polymerization is tied with a stiffening ECM and hypertrophic differentiation 
(20,48,125), suppressing sox9 transcription factor expression and varying chondrogenic 
markers through RhoA/ROCK signaling (72). Rhoa1 was not seen to be consistent with 
actin polymerization, though transcription of this factor does not indicate the level of 
translated or activated RhoA (72). Chondrogenic non-infected and GFP-transduced cells 
decrease intensity of g-actin staining four hours post loading, potentially increasing the 
ability of the cell to deform under compression (114). Cyclic compressive loading 
upregulated cofilin in agarose-embedded chondrocytes, possibly explaining the decrease 
of cortical actin cortical staining following load. An upregulation of depolymerizing 
proteins and β-thymosins cause an inhibition of actin polymerization (120) instead of a 
direct mechanical breakdown (114). 
Knockdown samples also demonstrated control over VIF organization, lacking the 
dynamically increasing response seen in non-infected growth and chondrogenic and GFP-
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transduced cells. Growth samples at day 7 measured a significantly lower intensity and 
knockdown samples a higher intensity in free-swelling, which did not change intensity 
levels following mechanical compression.  The dynamic response of these proteins is not 
necessarily dependent on the initial amount of protein available, but potentially more 
dependent on the deformability of the cell or the matrix-membrane interactions. Vimentin 
contributes to the integrity of the chondrocyte cytoskeleton, with a decrease in vimentin 
causing a decrease in the overall mechanical properties of the cell (116). Vimentin 
proteins increase during chondrogenesis (77) and are highly involved in chondrogenic 
marker expression possibly through PKA phosphorylation (77).  VIFs and MTs 
demonstrate spatial similarity and increase directly related to the accumulation of PCM 
surrounding chondrocytes (122). A decrease in VIF content and organization is seen with 
osteoarthritis (116) and in vitro disruption of VIFs and MTs causes a decrease in sGAG 
and collagen synthesis and transcription (117,126). MT intensity was dynamic in all 
chondrogenic cells, with an overall decreasing intensity in knockdown samples following 
load. Both VIFs and MTs are involved in the synthesis and secretion of proteoglycans in 
response to mechanical stimulation (126). The stimulatory effect of MT dynamic 
turnover is also directly related to the stage of differentiation, with hypertrophic 
chondrocytes expressing a higher level of MTs than proliferative chondrocytes (118) 
which stimulate type X collagen synthesis and ALP activity. The higher intensity of MT 
staining and lack of dynamic response of AMF and VIF in shColVI samples could 
demonstrate an early shift towards hypertrophic differentiation which is unaffected by 
dynamic loading.  
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These cytoskeletal proteins directly transmit mechanical forces from the cell 
membrane, causing direct effects on chondrogenic gene expression following mechanical 
stimulation (13,115,127). Compression stimulates signaling pathways involving p38, 
mitogen-activated protein kinases (MAPK), cFos and cJun (63). These signaling cascades 
could be caused not only by a changing cytoskeleton, but by cell-membrane channels 
involved in ATP release (109) and changes in cellular volume and surface area (16,110).  
Comp is mechanically activated in chondrocytes, having higher gene and protein 
expression levels in chondrocytes when dynamically cultured both in explants and when 
cultured in alginate in the presence of TGF-β for 14 days (107). COMP is both activated 
by TGF- β and causes TGF- β enhanced signaling (128). ShDcn samples showed a 
significantly higher expression of comp at day 7 in free-swelling and loaded samples, 
which decreased approximately four hours post loading. DCN sequesters TGF- β 
(3,21,62), controlling the growth factor presentation to the cell, and is stimulated directly 
through mechanical compression (65). Without DCN regulation, COMP protein could be 
continuously activating itself through this TGF- β signaling. COMP also enhances TGF- 
β efficiency through multiple binding sites of the growth factor increasing membrane 
presentation (128).  This high upregulation in shDcn samples was decreased by day 14, 
matching the chondrogenic non-infected and GFP-transduced samples. With DCN 
knockdown samples at day 14, comp expression showed an initial decrease following 
loading, opposite to the chondrogenic controls. Comp upregulation has been tied to α1 
integrin mechanotransduction (107), directly tying integrin-collagen interactions to the 
comp mechanotransduction regulation.  
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FGF2 has been seen to be important during dynamic loading, being released from its 
heparin sulfate GAG chains to stimulate the cell membrane (129,130) and has been seen 
to suppress aggrecanolysis by ADAMTS5 (131). The similar late onset following load for 
fgf2 and bmp6 could distinguish their expression as further down the mechanosignaling 
cascade and potentially competing for phenotype expression. FGF2 has inhibitory effects 
on BMP6 during chondrogenic culture (132). Bmp6 is dynamically upregulated in pre-
chondrogenic hMSCs (53) and is considered a potent inducer of osteogenic phenotype 
(133). Bmp6 is activated through different SMAD receptors than TGF-β (134), with 
TGF-β inhibiting and BMP6 activating hypertrophic differentiation. When BMP6 is 
activated, there are significant increases in ColX and ALP expression. The more robust 
response of bmp6 and fgf2 at day 14 is potentially tied to the shift in AMF and MT 
dynamics in shColVI samples, demonstrating further acceleration towards a hypertrophic 
phenotype in ColVI knockdown samples. The same gene expression shift was unseen in 
shDcn cells, which actually shows an earlier peak response at 1 hour following load, 
though this is insignificant. Therefore the lack of VIF dynamics at day 14 in knockdown 
samples is not the direct influence on fgf2and bmp6 signaling.  
Stimulation of hMSCs during chondrogenesis is highly dependent on the duration 
(135), frequency (67,111), and amplitude of applied physiologic loading. Short term 
mechanical compression allows a narrower examination of activated cell signaling for 
understanding of longer duration matrix metabolic changes. Cells maintain their 
micromechanical environments through by balancing anabolic and catabolic responses to 
applied forces (106,135). The shift in matrix composition during osteoarthritis is 
considered to cause a change in the mechanical signaling cascade within chondrocytes, 
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causing the matrix to further degrade. We have demonstrated control over cytoskeletal 
dynamics and gene expression through targeted subtraction of PCM components. 
Intrinsically controlling mechanotransduction events using shRNA-mediated RNAi in 
differentiating hMSCs can aid regenerative therapies in overcoming the loss of structural 
integrity in degenerating load bearing tissues.  
5.5 Conclusion 
This study determined how ColVI and DCN directly affected cytoskeletal and 
mechanosignaling events during chondrogenic differentiation. ColVI and DCN 
knockdown arrested a dynamic response of cytoskeletal AMF and VIF reorganization 
following load. The higher fluorescence levels of AMF and VIF demonstrate a cellular 
stiffening to compensate for the altered micromechanical environment. These changes 
then cause a shift in mechanosignaling initiation. This study was the first to our 
knowledge to determine a relationship between ColVI and fgf2 and bmp6 
mechanosignaling as well as the direct control of DCN over comp expression. 
Understanding how these proteins are involved in mechanosignaling initiation advances 
the ability to control the gene expression cascade following load. Further examination of 
how these proteins are involved in long term mechanotransduction events is needed to 




Chapter 6: ColVI and DCN's influence on cell-seeded alginate 
scaffold material properties and chondrogenic gene expression 
during long term dynamic compressive culture
3 
6.1 Introduction 
Articular cartilage is composed of a complex network of collagens, specifically types I 
and II (21), proteoglycans (PGs), and non-collagenous proteins. These proteins are 
interwoven to withstand a complex combination of compression, tension and hydrostatic 
pressure during loading and transduce a safe level of mechanical stimulation to the cell to 
elicit a biochemical response. The cartilage extracellular matrix (ECM) is maintained 
through a balance of anabolic and catabolic effects caused by these environmental cues 
(106). The thin 2-6 µm pericellular matrix (PCM) developed during chondrogenesis 
enveloping the cell directly controls the metabolic activity of articular chondrocytes and 
chondrogenic human mesenchymal stem cells (hMSCs) in response to dynamic loading 
(13).  
The PCM is composed of type VI collagen (ColVI) (17,22), hyaluronan (98), 
fibronectin, and PGs such as decorin (DCN), biglycan (BGN), perlecan (130) and 
aggrecan (17,123), which give the PCM biochemical and mechanical properties distinct 
from the surrounding extracellular matrix (ECM) (22,100). These proteins are 
accumulated in a temporally specific manner, with peaks of PGs and collagens and 
matrix organizing proteins, such as cartilage oligomeric matrix protein (COMP) (123), 
varying within 
___________________________________________________________________ 
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two weeks of chondrogenic induction (3,4,52,123). Exogenous addition of members of 
the transforming growth factor (TGF) family will cause hMSCs to commit to the 
chondrogenic lineage as well as simulated physiologic loading (55). Dynamic loading not 
only increases endogenous TGF-β release (97), directly improves matrix elaboration and 
GAG synthesis (30,39,44,52,54,97). 
Mechanical stimulation in combination with growth factor chondrogenic induction has 
shown varying effects on chondrogenic phenotype with a complex pattern of gene 
expression (54,55). Dual stimulation causes more robust type II collagen synthesis 
(14,52,54), but does not show an additive effect on aggrecan expression (52). While 
chondrogenic markers are upregulated under dynamic stimulation, this may also increase 
the rate of terminal differentiation, increasing type X and type I collagen expression 
(54,97). Differentiation of hMSCs into physiologically functional chondrocyte like cells 
needs correct temporal applications of chemical and mechanical stimuli (45) and an 
understanding of how the cell responds to these specific stimulations.  
We have previously shown that ColVI and DCN are highly involved in PCM 
expression and accumulation (113). ColVI knockdown decreased, while DCN 
knockdown accelerated PG and comp expression during the two week induction period. 
The change in proteoglycan content and knockdown proteins caused a higher cellular 
deformability under applied compression in shColVI samples and a highly irregular 
organized matrix in shDcn samples which act in a strain dependent manner (113). The 
shift in deformability altered the cytoskeletal mechanics and will change the transmission 
of forces to the nucleus (71).  
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Current studies have focused on understanding how mechanical load stimulates 
chondrogenesis, in the presence or absence of TGF-β (12,14,55) and in the presence or 
absence of an elaborated matrix (45,55). Whether the findings of improved 
chondrogenesis from initial matrix elaboration prior to dynamic stimulation are due to 
initial collagen or PG signaling or the changing mechanical properties has yet to be 
determined. This study analyzes the contribution of type VI collagen and decorin in 
chondrogenic gene expression, MSC proliferation, and the biomechanical composition of 
cell-seeded scaffolds during chondrogenic culture with the dual stimulation of TGF-β and 
dynamic compression. We believe that ColVI and DCN are highly involved in the matrix 
accumulation caused by dynamic compressive culture and that targeted knockdown of 
these proteins will significantly alter the biomechanical and biochemical composition of 
the developed matrix. 
6.2 Materials and Methods 
6.2.1 Cell culture and viral transduction 
HMSCs were expanded in monolayer using a basal non-differentiation growth media 
(GM) containing high glucose DMEM (HG-DMEM) (Gibco/Invitrogen, Carlsbad, CA) 
supplemented with 10% fetal bovine serum (FBS) (Gibco), 100U/mL 
penicillin/streptomycin (Gibco), 1% MEM non-essential amino acids (Gibco), and 4mM 
L-Glutamine (Invitrogen) until passage 4. Cells were cultured at 37°C with 5% CO2 with 
media changes three times per week. 
HMSCs were separated into either non-infected or infected experimental samples. 
Infected experimental samples were treated with shRNA lentiviral vectors targeting either 
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human col6a1 mRNA (shColVI) (Gen Bank: NM_001848), dcn mRNA (shDcn) 
(GenBank: NM_001920) (Table 6.1), or a GFP expression vector  as previously 
described (113).  
 








Table 6.1: Sense and anti-sense hairpin sequences for shColVI and shDcn. 
All vectors included a blasticidin resistance gene with a U6 promoter and a PolIII 
termination sequence. Cells were infected at a multiplicity of infection (MOI) of 1 in the 
presence of 6µg/mL Polybrene (Sigma) to aid in transduction efficiency for 24 hours as 
previously described (113).  MOI was determined for each lentiviral vector through a 
Quant-IT PicoGreen (Invitrogen) titer assay. 48 hours following viral removal, cells were 
incubated with GM containing 12 µg/mL of blasticidin to select for a pure population of 
transduced cells as previously described. After selection, non-infected and infected cells 
were lifted from monolayer using 0.25% trypsin-EDTA (Gibco), centrifuged at 600xg for 
5 minutes before being re-suspended in a 2% (w/v) alginate solution (Research Products 
International, Mount Prospect, IL) at a concentration of 2.0 x 10
6
 cells/mL. Alginate 
disks were formed as previously described by pipetting the cell-alginate solution into 
cylindrical disk-shaped molds (Ø 6mm x 3 mm in height) with a 5 µm porous membrane 
and Whatman filter paper attached to the top and bottom faces of the molds (92). Molds 
were immersed in a 102 mM CaCl2 bath for 90 minutes to ensure complete alginate 
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crosslinking. To maintain position and unconfined conditions during loading, Ø8mm 
wells were punched out of a 1.5 mm thick layer of agarose pre-cast into Ø60 mm petri 
dishes(43,44), and alginate-cell disk constructs were each placed into a pre-formed well. 
Each petri dish was able to accommodate six constructs. All cell constructs were allowed 
to equilibrate in free-swelling conditions overnight prior to bioreactor culture. One non-
infected cell group was cultured in GM. The remaining non-infected group and all 
transduced cell constructs were cultured in chondrogenic induction media (CM) 
containing HG-DMEM, ITS Universal Culture Supplement Premix (BD Biosciences, San 
Jose, CA), 10nM dexamethasone, 50µg/mL L-ascorbic acid (Sigma), 40 µg/mL L-Proline 
(Sigma), 100U/mL penicillin/streptomycin, 1mM sodium pyruvate, 0.584 g/mL L-
glutamine, and 10ng/mL TGF-β3 (Lonza). All samples were cultured for 7 or 14 days at 
37°C with 5% CO2 with media changes three times per week. For qRT-PCR baseline 
controls, some disks were collected at day 1 of free-swelling GM culture prior to 
bioreactor loading.  
6.2.2 Dynamic mechanical stimulation of cell-seeded alginate constructs 
The Ø60 mm petri dishes containing the cell-seeded alginate disks and 1.5mm height 
agarose molds were placed into Ø 62 mm culture chambers of a custom designed 
polysulfone bioreactor. The bioreactor contains four culture chambers centered on a 
Zaber linear actuator (Zaber NA11B16, Zaber Technologies Inc., British Columbia, 
Canada) (fig. 6.1A). The polysulfone lid of the bioreactor consisted of four loading 
platens of Ø 50mm that would center above and be concentric with the culture chambers 
when attached to the motor (fig. 6.1 D and 6.1E). Assembled, the polysulfone lid 
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overlaps the base to ensure sterility within the bioreactor chambers and the entire 
assembly is maintained in a 37°C, 5% CO2 incubator (fig. 6.1B). 
 
 
Fig. 6.1: Custom designed polysulfone bioreactor designed to apply displacement controlled 
sinusoidal unconfined compression. (A) The bioreactor has four culture wells centrally located 
around the Zaber linear actuator. Each well contains one Ø60 mm petri dishes with alginate disks 
(Ø6 mm x 3 mm in height) maintained in an agarose mold. (B) Once assembled, the polysulfone 
lid overlaps the base to ensure sterility while allowing free gas-exchange during loading while 
maintained in a temperature and gas controlled incubator. (D) The Ø50 mm loading platens are 
designed to concentrically locate above the individual wells to apply homogenous displacement 
controlled strain across all disks (E). Non-loaded (NL) static contact cultures incorporated an 
aluminum platen to maintain 0% strain for four hours per day (C,F) to mimic the nutrient 
diffusion limitations within the bioreactor.  
Sinusoidal compression was applied at 0.1Hz from 2-12% strain for four hours per day 
for dynamically cultured samples. All compression was displacement controlled. 
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Following the loading duration, samples were removed from the bioreactor and returned 
to free-swelling conditions.  Samples were cultured with alternating loading and free 
swell periods for 7 or 14 days, at which point disks were separated for viability, gene 
expression, mechanical property analysis, DNA quantification, histology, and 
immunofluorescence (fig. 6.2).  
 
Fig. 6.2: Schematic of loading duration and harvest points.  
Static non-loaded (NL) controls were cultured in parallel with platens placed on the 
alginate-cell scaffolds which maintained 0% strain, to prevent axial swelling and to 
mimic the diffusive qualities of the bioreactor platens (fig. 6.1C and 6.1F). These controls 
were subjected to the same daily alternating static contact condition for four hours and 
free-swelling condition for 20 hours. 
6.2.3 Gene expression 
Samples were collected from loaded and non-loaded cultures at day 7 and 14. Day 1 
samples, prior to bioreactor culture were also harvested as a baseline control. Cells were 
recovered from cell-alginate constructs by immersion in a 100mM sodium citrate, 30mM 
EDTA solution as previously described. Cells were centrifuged at 600xg for five minutes 
and then resuspended in a buffer solution containing β-Mercaptoethanol (Fisher 
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Scientific, Pittsburgh, PA) before flash freezing. RNA was isolated (RNeasy Micro, 
Qiagen, CA) and total RNA was reverse transcribed. Gene expression was analyzed using 
qRT-PCR (MyiQ System, BioRad, CA) with primers designed for human genes (Table 
6.2) using Primer3 software. Gene expression levels for 18s, acan, adamts4, bgn, col1a1, 
col2a1, col6a1, comp, dcn, fgf2, runx2, and sox9 were quantitatively assessed as 
previously described (113,136). All primer amplification efficiencies were determined 
using linear regression efficiency methods and were determined to be between 89.4% and 
117.7% efficient (R
2
>0.99) (90). Expression levels were analyzed using the ΔΔCt 
method. Cycle threshold (Ct) values were averaged and ΔCt was calculated by 
subtracting the average Ct values of the internal control gene GAPDH from that of the 
gene of interest (ΔCtcol6a1=Ctcol6a1- CtGAPDH) as previously described. ΔΔCt for each gene 
of interest was determined by subtracting the ΔCt of day 1 samples from the experimental 
ΔCt at each time point (i.e. col6a1 expression shColVI samples cultured in the bioreactor 
for 7 days: ΔΔCtcol6a1,shColVI, BR-D7 = (ΔCtcol6a1,shColVI, BR-D7 – ΔCt col6a1,day 1)). Relative gene 
expression levels (fold difference) were computed though the exponential relation 2
-ΔΔCt
  





) ± half the range.  
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Table 6.2: Sequences of Primers used for Aim 3 qRT-PCR. 
6.2.4 Material Properties 
To determine the changing micromechanical properties of the PCM within the alginate 
disks, unconfined stress-relaxation tests were performed using an Ø 7mm stainless steel 
chamber and a Ø6mm plunger attached in series with a 200g load cell. These components 
were attached to and controlled by a materials testing system (LM-1, Bose/Electroforce, 
Eden Prairie, MN). Disks were initially loaded with a 2g tare load and then maintained at 
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the achieved displacement for 5 minutes. Constructs underwent three rampings of 
displacement controlled 10% strain applied at 0.05%/second (55,137) followed by 1000 
seconds of relaxation (55). Force and displacement measurements were collected during 
each mechanical test. From the individual rampings, viscosity (η), instantaneous (E1+E2) 
and steady state stiffnesses (E1) were determined using the linear standard solid model for 





       (fig. 6.3). E1 and E2 show the stiffness 
changes during the stress relaxation and η represents the viscous time-dependent behavior 
of the disk.  Data were analyzed with the curve fitting toolbox using Matlab (Mathworks, 
Natick, MA). 
 
Fig. 6.3: Standard Linear Solid model was used to determine the mechanical properties of the 
stress-relaxation tests. (A) Representative spring-dashpot schematic of the standard linear solid 
model, where E1, E2, and η represent changing material properties under applied strain. E1+ E2 
represents the instantaneous stiffness under an applied compression, E1 represents the steady state 
stiffness of the construct, and η represents the viscosity of the changing disk under applied load. 
(B) Representative stress and strain curve vs. time for chondrogenic non-infected cells at day 14. 
(C) The standard linear solid model can determine the changing material properties from 
collected force and displacement data. 
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6.2.5 DNA quantitation 
DNA was isolated from disks to determine effects of loaded and non-loaded culture on 
cellular proliferation. Cells were isolated from their alginate scaffolds using a 100mM 
sodium citrate, 30mM EDTA solution as previously described. Cells were separated from 
the alginate solution by spinning down at 600xg for five minutes before being 
resuspended in Tris-EDTA buffer and flash freezing. DNA was isolated using a DNeasy 
Tissue Kit (Qiagen, Valencia, CA), resulting in 400 µL of DNA eluate. DNA was 
quantified using the Quant-iT PicoGreen kit according to manufacturer’s instructions 
with a calibration curve generated from Lamda DNA. Fluorescence intensity was 
measured using a SpectraMax M5 plate reader (Molecular Devices, Sunnyvale, CA).  
6.2.6 Statistical Analysis 
Statistical analyses for gene expression, mechanical properties, and DNA quantitation 
were performed using one-way ANOVA. Tukey's HSD post hoc tests were performed for 
pairwise comparisons. All computations were performed using JMP7 (Cary, NC) with 
statistical significance set to α<0.05 as indicated in results.  
6.3 Results 
6.3.1 Targeted knockdown was unaffected by dynamic culture 
Significant knockdown of col6a1 and dcn was achieved over the 14 day experiment 
with lower expression levels in shColVI and shDcn-transduced cells in both non-loaded 
and bioreactor culture conditions. Expression of col6a1 was reduced by 47-77% in the 
shColVI group compared to CM (fig. 6.4: col6a1 gene expression: CM (D7-NL: 7.994± 
2.246; D7-BR: 8.180± 2.242; D14-NL: 5.736± 1.486; D14-BR: 4.442± 1.422), GFP (D7-
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NL: 7.521± 2.379; D7-BR: 5.838± 1.790; D14-NL: 5.204± 1.384 ; D14-BR: 3.340± 
1.190), and shColVI: (D7-NL: 4.232±  1.215; D7-BR: 3.489± 1.331; D14-NL: 2.75±  
0.698; D14-BR: 1.012±  0.348)). Expression of dcn decreased by 85-95% in the shDcn 
group compared to CM (dcn expression levels: CM (D7-NL: 2.661± 1.107; D7-BR: 
4.34± 1.973; D14-NL: 1.349± 0.429; D14-BR: 1.831±0.485), GFP (D7-NL: 3.301± 
0.892; D7-BR: 2.412± 1.858; D14-NL: 0.306± 0.080; D14-BR: 0.540± 0.322), and 
shDcn (D7-NL: 0.412± 0.239; D7-BR: 0.619± 0.178; D14-NL: 0.093± 0.029; D14-BR: 
0.088± 0.072)).  
 
Fig. 6.4: Relative col6a1 and dcn gene expression (fold difference) of day 7 and day 14 non-
infected GM and CM cells and GFP-, shColVI-, and shDcn- transduced cells in non-loaded and 
bioreactor culture to day 1 cultures. (#:p<0.05 from GM samples at each time point; *:p<0.05 
from CM & GFP at each time point; +:p<0.05 between non-loaded and bioreactor cultured 
samples; @: p<0.05 between day 7 to day 14 culture; n≥ 3). 
6.3.2 Dynamic culture affected DNA quantity in non-infected samples 
DNA content showed no significant differences between non-loaded and dynamically 
cultured samples at either time point in any of the chondrogenic conditions, but dynamic 
loading did affect GM samples at day 14 (fig. 6.5). GFP-, shColVI- and shDcn- 
transduced resulted in significantly lower DNA content than growth and chondrogenic 
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non-infected cells at both time points. Previous studies have not shown a significant 
difference in viability between non-infected and viral transduced cells (113). TGF- β 
culture has shown an increase in proliferative capacity initially in hMSCs (52), which 
could correspond to the increase in DNA content in non-infected CM samples between 
days 7 and 14.  
 
Fig. 6.5: Ratio of DNA content between bioreactor cultured and non-loaded disks in non-infected 
GM and CM and GFP-, shColVI-, and shDcn-transduced cells disks at 7 or 14 days. DNA was 
quantified using Quant-iT Picogreen and a lambda DNA standard curve Data shown is the 
average DNA concentration (ng/mL) of bioreactor culture / average DNA concentration in non-
loaded samples (ng/mL) + standard deviation. (+:p<0.05 between non loaded and bioreactor 
cultured samples; n≥ 5). 
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6.3.3 Dynamic culture affected material properties only after two weeks of culture 
 Mechanical properties of cell-seeded alginate scaffolds determined from stress-
relaxation tests and the standard linear solid model were affected by both culture duration 
and dynamic loading. At day 7, mechanical characteristics were not significantly affected 
in chondrogenic medium cultured samples. CM and GFP samples had a slight decrease in 
their viscosity parameter under dynamic load, which was opposite in growth media 
conditions (fig. 6.6). The increase in GM viscosity was significantly higher than 
chondrogenic alginate disks. This trend was opposite at day 14, where dynamic load no 
longer affected the growth media samples, but increased the viscosity parameter in 
chondrogenic samples (fig. 6.7). The viscosity of the disk affects the rate of relaxation 
and stress dissipation under an applied compression, which will be indicative of the  
matrix elaborated and hydration levels. Growth media samples showed significantly 
higher viscosity, instantaneous and steady state stiffness parameters at day 14 in non-
loaded cultures than chondrogenic samples. These properties all decreased with time 
from day 7 to day 14 in the chondrogenic cultures. By day 14 when cells will have 
developed a full PCM enveloping themselves (113),  dynamic loading increased the 
viscosity and steady state stiffness of CM and GFP samples to match these growth media 
parameters at day 14. These increases in steady state stiffness in bioreactor culture could 
be potentially due to a stiffer matrix and higher synthesis and accumulation of proteins 
within the cell-alginate scaffolds. The instantaneous stiffness under applied compression 





Fig. 6.6: Mechanical properties of non-infected GM and CM, and GFP-transduced cell alginate 
disks in either non-loaded (NL) or bioreactor (BR) culture for 7 days. Viscosity (η), instantaneous 
(E1+E2) stiffness, and steady-state (E1) stiffness was unaffected at day 7.  All properties were 
determined using displacement controlled stress-relaxation tests with 10% strain applied at 
0.05%/second, which was maintained for 1000 seconds. Stress and strain calculations were 
determined from the force and displacement data collected. Mechanical properties were 





      . (#:p<0.05 from GM 
samples at each time point; *:p<0.05 from CM & GFP at each time point; +:p<0.05 between non-





Fig. 6.7: Mechanical properties of non-infected GM, CM, and GFP-transduced cell alginate disks 
in either non-loaded (NL) or bioreactor (BR) culture for 14 days. Steady-state (E1) stiffness 
significantly increased with dynamic culture.  All properties were determined using displacement 
controlled stress-relaxation tests with 10% strain applied at 0.05%/second, which was maintained 
for 1000 seconds. Stress and strain calculations were determined from the force and displacement 
data collected. Mechanical properties were determined from standard linear solid model:   
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6.3.4 Dynamic stimulation does not enhance gene expression in conjunction with TGF-β 
culture 
Mechanical stimulation demonstrated a strong control over chondrogenic gene 
expression, upregulating bgn, acan, col1a1, and fgf2 in GM samples to similar levels of 
chondrogenic non-infected and GFP-transduced cells (fig. 6.8). These samples resulted in 
a much higher response to loading than chondrogenic samples, demonstrating the 
competing mechanical and biochemical induction of the TGF-β pathway. Similar levels 
of chondrogenic gene expression was seen between loaded and non-loaded samples in 
CM and GFP samples.  
Dynamic stimulation affected some chondrogenic markers, with fgf2 remaining highly 
responsive, col2a1, runx2, and sox9 expression levels were minimally different between 
time points and with dynamic loading. Hypertrophic gene expression was inhibited when 
dynamically loaded (fig. 6.8). While mechanical and biochemical induction of 
chondrogenesis may compete and decrease chondrogenic marker expression compared to 





Fig. 6.8: Relative comp, acan, bgn,  col1a1, fgf2, and adamts4 gene expression (fold difference) 
of day 7 and day 14 non-infected GM and CM cells and GFP- transduced cells in non-loaded 
(yellow) and bioreactor (red) culture to day 1 cultures. (#:p<0.05 from GM samples at each time 
point; *:p<0.05 from CM & GFP at each time point; +:p<0.05 between non-loaded and bioreactor 




6.3.5 ColVI and DCN knockdown caused varying material changes to dynamic culture 
The contribution of ColVI and DCN were more drastic at day 14 than day 7 in alginate 
scaffold material properties (fig. 6.9). DCN knockdown caused an increase in the 
instantaneous stiffness at day 7, which wasn’t seen at day 14. Dynamic culture did not 
affect any other properties in other conditions at day 7.  
Bioreactor cultured shColVI samples showed a significant increase in instantaneous 
and long term stiffness. Dynamic culture potentially affected the matrix elaboration 
therefore changing the viscosity and instantaneous stiffness of the whole scaffold. ShDcn 
samples were the only chondrogenic condition at day 14 in which long term stiffness was 
unchanged by bioreactor culture.  ShDcn samples that underwent unloaded culture had 
significantly higher viscosity and stiffness parameters at day 14, of which only the 
viscosity and instantaneous stiffness were affected under dynamic culture. ColVI 
knockdown samples may cause significant changes when dynamically cultured, but 






Fig. 6.9: Mechanical properties of shColVI-, and shDcn- transduced cell alginate disks in either 
static (NL) or bioreactor (BR) culture for 7 or 14 days. Viscosity (η), instantaneous (E1+E2) 
stiffness, and steady-state (E1) stiffness were affected in all shColVI samples at day 14. Viscosity 
was affected in shDcn samples at day 14. All properties were determined using displacement 
controlled stress-relaxation tests with 10% strain applied at 0.05%/second, which was maintained 
for 1000 seconds. Stress and strain calculations were determined from the force and displacement 
data collected. Mechanical properties were determined from standard linear solid model:    
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6.3.6 Targeted PCM knockdown had a greater effect on gene expression than dynamic 
compressive culture 
Knockdown samples showed varied regulation over gene expression under non-loaded 
and dynamic culture conditions. In both knockdown samples, adamts4 expression was 
higher in knockdown samples than all other conditions and continuously decreased with 
culture and dynamic loading. This expression profile was only seen in knockdown 
samples. Adamts4 and fgf2 expression profiles were opposite and potentially antagonistic 
in shColVI samples. Fgf2 expression was similar in non-loaded knockdown samples at 
day 7, but shColVI samples showed an increase in expression under dynamic culture, 
which then increased with time. This same expression profile was seen in the GM 
samples (fig. 6.8). ShDcn knockdown samples did not show an fgf2 responsiveness to 
bioreactor culture (fig. 6.10), maintaining levels from day 7 to day 14 under dynamic 
loading, which decreased over time in non-loaded conditions.  
Acan and bgn expression were both slightly increased under load in shColVI samples 
at day 7 and then significantly lower at day 14. Acan expression was lower at all time 
points in ColVI knockdown samples than all other conditions which continued to 
decrease expression at day 14, which wasn’t recovered by dynamic stimulation. Comp 
levels were lower in ColVI than all other chondrogenic samples, and decreased over the 




Fig. 6.10: Relative comp, acan, bgn,  col1a1, fgf2, and adamts4 gene expression (fold difference) 
of day 7 and day 14 shColVI- transduced cells in non-loaded (yellow) and bioreactor (red) culture 
to day 1 cultures. (#:p<0.05 from GM samples at each time point; *:p<0.05 from CM & GFP at 
each time point; +:p<0.05 between non-loaded to bioreactor cultured samples; @: p<0.05 
between day 7 to day 14 culture; n≥3). 
shDcn non-loaded samples showed a higher expression of comp, acan, bgn, and 
col1a1 in non-loaded samples at day 7 that was returned to levels similar to chondrogenic 
non-infected and GFP-transduced cells. These levels were then significantly lower at day 
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14 than other samples, possibly due to the shift in peak levels during chondrogenic 
induction.  
 
Fig. 6.11: Relative comp, acan, bgn,  col1a1, fgf2, and adamts4 gene expression (fold difference) 
of day 7 and day 14 shDcn- transduced cells in non-loaded (yellow) and bioreactor (red) culture 
to day 1 cultures. (#:p<0.05 from GM samples at each time point; *:p<0.05 from CM & GFP at 
each time point; +:p<0.05 between non-loaded to bioreactor cultured samples; @: p<0.05 





Dynamic compression and chemical induction of chondrogenesis has shown complex 
regulation over gene expression, with combined stimulation inhibiting the rate of 
differentiation and the accumulation of GAG and collagens (14,54,55) compared to 
growth factor or compressive culture alone. Matrix development will shift the 
deformability of chondrogenic hMSCs, changing the means through which cells perceive 
mechanical stress. Regenerative therapies seek to include dynamic culture to improve 
material properties (44), increase matrix homogeneity, activate endogenous TGF release 
(65,138), and collagen synthesis (14,44,52) caused not only by direct mechanical 
compression, but increased fluid shear and nutrient delivery (13,138,139).  
We have previously seen that altering individual proteins within the PCM has 
implications on the accumulation and organization of elaborated matrix during 
chondrogenesis (113). ColVI and DCN knockdown causes a change in proteoglycan 
expression, deformability under applied compression (113), and cytoskeletal responses to 
loading. In the present study, we examined the contribution of type VI collagen and 
decorin in gene expression and scaffold mechanical properties under dynamic culture. 
Changing the elaboration of the matrix will cause a shift in macroscopic scaffold 
properties as well as the micromechanical properties of the PCM. This study 
demonstrates a means to engineer a scaffold's material properties through control over 
individual proteins as well as elucidating the relationship between ColVI and DCN and 
cellular responses to dynamic stimulation.  
One of the major findings of this study was the competing expression levels between 
non-loaded and dynamic culture in shDcn knockdown samples. DCN knockdown caused 
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a large upregulation of chondrogenic markers at day 7 which was inhibited under 
bioreactor culture. This stimulation of chondrogenic markers was only specific to 
proteoglycan and comp,  unaffecting col2a1 expression. DCN is known to sequester 
TGF- β (3,21,62), controlling the growth factor availability to the differentiating cell. 
Lack of regulation and the self-promoting activation of COMP will increase 
chondrogenic markers directly stimulated by TGF-β3 (107). COMP is activated by TGF- 
β and is self stimulated through binding and presenting the growth factor back to the cell 
membrane (4,128). Comp is also upregulated in mechanically loaded chondrocytes when 
in the presence of TGF- β (107,128).  Comp over expression in DCN knockdown samples 
has previously shown inhibition by transient loading during the matrix organization phase 
of chondrogenesis. The direct control that DCN has over comp expression is either 
inhibited by the changing environment during mechanical stimulation or by a competing 
pathway during the first 7 days of chondrogenesis.  
The mechanical stimulation of certain genes was shown to be dependent on 
chondrogenic induction or PCM development (55). Growth media samples showed 
drastic upregulations of adamts4, fgf2, bgn, and comp expression at both time points 
under dynamic culture, which was only seen in shColVI samples for bgn and fgf2. GM 
and shColVI samples both lack the ability to maintain a round cell shape under applied 
compression which directly impacted actin microfilament dynamics and organization in 
response to load (113). Fgf2 expression therefore may be directly dependent on cell shape 
changes during loading. FGF-2 has conflicting results during chondrogenic culture, 
showing an inhibitive (132) or enhanced (3,131,140) affect on chondrogenesis (130), 
which is not currently linked directly to ColVI accumulation. FGF-2 is released from the 
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heparin sulfate GAG chains of perlecan during dynamic loading, directly stimulating the 
cell membrane (129,130), and has been shown to suppress enzymatic activity of A 
Disintegrin And Metalloproteinase with Thrombospondin Motifs-5 (ADAMT5) (131). 
The potential relationship between FGF2 and ADAMTS4 has not been explored. Altering 
the components of the PCM showed an increase in adamts4 expression in non-loaded 
knockdown samples, which was then decreased with loading.  Balancing anabolic and 
catabolic reactions in response to dynamic loading is imperative in maintaining a healthy 
PCM and ECM during chondrogenesis and scaffold maturation. When this balance is 
shifted catabolically, as seen in osteoarthritic or hypertrophic chondrocytes, with 
increases in metalloproteinase-2 (MMP-2) (30), tissue inhibitors of metalloproteinases-2 
(TIMP-2) (30,31), MMP-7 (31), MMP-13, ADAMTS-4, and ADAMTS5, there will be a 
biochemical and biomechanical breakdown of the matrix (27,28,123). 
Matrix elaboration within the hydrogel will directly shift the scaffold's bulk material 
properties, with increases in stiffness directly corresponding to increases in GAG 
(66,141) and collagen (142) synthesis. Material properties were determined to be directly 
related to matrix synthesis due to GM samples remaining unchanged with respect to 
duration and compressive culture. Chondrogenic culture maintained a steady level of 
acan, bgn, and col1a1 expression over the 14 days of chondrogenic culture in non-loaded 
samples, during which matrix elaboration caused a decrease in overall mechanical 
properties, contrary to what we expected. The bulk viscosity of the disc decreased with 
chondrogenic culture, resulting in lower material property levels than GM samples. 
Matrix synthesis and aggregation will also increase enzymatic activity, possibly 
expediting the breakdown of the scaffold. Steady state stiffness increased with dynamic 
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loading possibly due to a more homogenous matrix distribution and higher collagen 
content throughout the disk, which was also seen in shColVI samples (55). Instantaneous 
stiffness and viscosity parameters were similar in loaded and non-loaded samples, due to 
similar matrix expression levels. Fluid pressure within hydrogels are a large contributor 
the instantaneous stiffness (44).  Previous studies examining scaffold properties during 
chondrocyte culture has shown peak equilibrium moduli (44) and GAG content (44) after 
2 weeks of culture.  
PCM development in cartilage demonstrates an increase in elastic behavior (5), with 
alterations in ColVI content significantly decreasing these material properties. The 
alteration of the PCM by targeted protein knockdown will directly affect the biphasic 
viscoelastic behavior of the PCM (5,19), with the lack of organization affecting the 
compaction and release of the matrix following load. ColVI knockdown causes a 
decrease in proteoglycan content (113), together altering the overall biophysical 
microenvironment surrounding chondrogenic hMSCs. Knockdown effects on mechanical 
behavior disparities between loaded and non-loaded culture of the cell-seeded alginate 
discs were only observed after 14 days. ColVI knockdown in conjunction with dynamic 
stimulation increased all material properties under bioreactor culture, contrary to 
expected results. While the transcriptional regulation of col1a1 was not increased in 
shColVI samples, the knockdown could also be causing a more osteoarthritic matrix 
development (5). The increase in viscosity was increased potentially due to the looser 
matrix and higher catabolic reactions. Osteoarthritic breakdown of proteoglycans causes 
a decrease in matrix organization and an increase in overall PCM and cell volume, with 
type VI collagen lacking organization and increasing radial distance from the cell (1).  
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Dynamic stimulation has improved GAG synthesis, but may not improve GAG 
retention within the scaffold (97) depending on the initial elaboration of the matrix. The 
change in material property in knockdown samples may be due to an elevated enzymatic 
activity of ADAMTS4, which was highly expressed in knockdown samples relative to 
CM and GFP. ShDcn samples resulted in higher instantaneous and steady state stiffness 
parameters in non-loaded samples compared to CM, GFP, and shColVI samples. The 
increase in matrix properties will correspond to the higher COMP levels (143), which 
increases cross-linking of PCM proteins.  
The inhomogeneous material properties in hydrogel scaffolds during dynamic loading 
may be enhanced in knockdown samples causing the shift in mechanical composition 
(142). Dynamic loading has a much more significant effect on the bulk material 
properties of the scaffolds following two weeks of culture, therefore a longer culture 
duration may reveal a greater disparity in the material property differences caused by 
these two proteins (142). These measurements were determined to be an order of 
magnitude lower than observed elastic moduli of the pericellular matrix surrounding 
chondrocytes (81,144). Cell-seeding density directly relates to matrix elaboration and 
mechanical property improvements (43), therefore a more accurate determination of 
matrix properties should be determined through a higher cell-seeding density.  
Altering the composition of the PCM increases the compressive strains applied to the 
cell (113). The shifting mechanotransduction events due to this change in deformability 
caused significant changes in gene expression in knockdown samples, with a direct 
relationship determined between ColVI and fgf2 expression. To form a functional tissue 
engineering construct for articular cartilage repair, a more thorough understanding of the 
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relationship between scaffold material properties, biochemical composition, and the 
effects of dynamic stimulation is needed. The PCM demonstrates very specific 
mechanical properties that are frequency dependent (42), due to fluid flow within the 
PCM or to its biphasic behavior (19). The exact mechanism through which these proteins 
are affecting the overall scaffold material properties needs to be further explored through 
immunohistochemical analysis.  
Dynamic stimulation has been seen to improve matrix elaboration (55), sGAG 
synthesis (44), and collagen production (14,52), to closer mimic native cartilage 
properties. Development of a full PCM enhances the chondrogenic phenotype when 
dynamically stimulated (39,55,145), but this is highly dependent on cell-seeding 
density(142), application of TGF-β3(45), and method of loading 
(13,14,51,52,97,108,138,142). These parameters determine the maintenance of a 
chondrogenic phenotype, with synthesis of type II collagen and sGAG production, versus 
a more hypertrophic phenotype, increasing type I and X collagen expression (54,55,138). 
Exploring the roles of biochemical and biomechanical induction of chondrogenesis is 
important and determining the exact role of PCM proteins in these two mechanisms could 
further regenerative medicine for articular cartilage. Studies have demonstrated that a 
fully elaborated matrix prior to dynamic loading will enhance chondrogenic markers and 
matrix elaboration(55) within hydrogel culture. To determine the contribution of type VI 
collagen and decorin in mechanotransduction events following matrix elaboration, future 
experiments are planned to pre-culture samples for two weeks to allow a PCM to form 




Type VI collagen and decorin are highly involved in pericellular matrix elaboration 
and directly control mechanotransduction events. ColVI demonstrated a direct 
relationship to fgf2 expression, which has not been previously seen, and DCN control 
over comp expression was further revealed through the direct overexpression mechanism 
seen in unloaded samples. The shifts in gene expression caused a surprising effect on the 
overall biomechanical properties of the cell-seeded alginate scaffolds. This study not only 
demonstrates the ability to control the cell's biological response to dynamic stimulation 
through targeted knockdown, but the ability to engineer the overall bulk material 
properties through direct control over individual PCM proteins. Further studies are 
needed to thoroughly examine the mechanism through which ColVI and DCN 
knockdown are causing these disparities in material properties in long term dynamic 




Chapter 7: Conclusions and Future Work 
The overall aim of this work was to determine the method through which 
differentiating human mesenchymal stem cells sense their microenvironment to 
potentially control chondrogenic mechanotransduction events. The exact method through 
which mechanical stimulation is perceived is difficult to determine due to the temporally 
changing micromechanical environment. We sought to elucidate the contribution of type 
VI collagen and decorin in cellular biophysics, cytoskeletal dynamics, and 
mechanotransduction events (fig. 7.1). Understanding the relationship between 
pericellular matrix proteins and the cell's gene expression response to mechanical stress is 
necessary for advancing tissue engineering and regenerative strategies for articular 
cartilage repair.  
 
Fig. 7.1: Schematic outlining the overall goals of the three aims within this dissertation work. 
Aim 1 analyzed the biophysical contribution of ColVI and DCN, Aim 2 analyzed 
mechanosignaling gene expression and cytoskeletal kinetics following applied load, and Aim 3 
analyzed mechanical property and gene expression differences between knockdown and control 
samples under long term sinusoidal unconfined compression.  
 
Type VI collagen and decorin are necessary to maintain healthy cartilage (5,76,146) 
and a chondrogenic phenotype. ColVI knockout mice have shown increased OA 
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phenotype (5), more likely through control over the anabolic and catabolic biological 
responses of chondrocytes to mechanical stress than a breakdown of the tissue 
mechanical properties. ColVI knockout models showed an increase in articular cartilage 
fibrillation and a reduction in PCM strength. We wanted to analyze how ColVI was 
involved in maintaining the chondrocyte-like phenotype during chondorgenesis and in 
vitro culture to understand how this protein could be involved in OA development. 
Decorin is known to control ColVI microfibrillar organization (17,59,62,147) and growth 
factor sequestration within the PCM (62,87,105), assembling the PCM to maintain the 
chondrocyte-phenotype. Currently knockout models for decorin do not analyze the 
contribution of this proteoglycan in cartilage OA development or cartilage degradation. 
This thesis wanted to further explore how DCN is involved in the chondrogenic 
phenotype, not only to analyze how DCN is involved in cartilage maintenance, but how 
this protein could be used in therapeutic therapies.  
We first examined the effects of targeted knockdown of ColVI and DCN on 
chondrogenic differentiation of hMSCs, PCM gene expression, and the biophysical 
response to applied strain. These were determined using gene expression analysis through 
qRT-PCR, immunofluorescence microscopy, western blotting, and cellular deformation 
analysis under uniaxial unconfined static application of strain. Targeted knockdown was 
optimized and achieved as verified by a significant reduction in mRNA and protein 
expression of ColVI and DCN. Knockdown samples still successfully differentiated, with 
chondrogenic marker upregulation, but knockdown of ColVI and DCN caused a varying 
expression level from chondrogenic controls. Knockdown of ColVI caused a 
downregulation while knockdown of DCN caused an upregulation of acan and bgn. This 
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downregulation of proteoglycan gene expression within ColVI knockdown samples could 
lead to the hypertrophic phenotpye seen within OA knockout models (5,19,81). Aggrecan 
and biglycan are vital proteoglycans within PCM assembly. These alterations of the PCM 
composition caused a shift in the biophysical response, with ColVI deficient PCMs 
completely lacking the structural integrity to resist applied strain. DCN knockdown 
samples produced a strain dependent deformability under load potentially due to the 
increased GAG content or decreased collagen organization. The PCM with ColVI and 
DCN knockdown differ in their ability to resist applied deformation, demonstrating 
the difference in their contribution to the biophysical environment.  
Knowing that ColVI and DCN directly changed the deformability of the cell, 
mechanosignaling changes were determined. ColVI and DCN knockdown directly 
inhibited a dynamic response of g-actin and vimentin intermediate filaments following 
load. The cytoskeleton of chondrogenic hMSCs is highly reactive to mechanical 
stimulation transducing mechanical signals from the cell membrane to the nucleus. ColVI 
and DCN knockdown arrested this response by activating a higher AMF and VIF 
concentration in free-swelling conditions. The cytoskeleton will protect the cell from 
destructive loading, causing cellular stiffening to prevent injurious deformation. ColVI 
knockdown also demonstrated a direct relationship to fgf2 expression, which has not been 
previously seen.  We propose fgf2 expression is stimulated through cellular 
deformability. DCN knockdown also demonstrated a lack of TGF-β regulation, which 
caused the increased chondrogenic markers from aim 1, but also significant 
overexpression of comp. The TGF signaling pathway is activated through both 
biochemical and biomechanical means, which were shown to antagonistically compete in 
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shDcn samples. Currently the direct relationship between decorin and endogenous TGF-β 
secretion is unknown and being examined, but my work demonstrates the potential for 
decorin regulation over the TGF signaling pathway. The direct of fgf2 expression in 
ColVI knockdown samples and of comp expression in DCN knockdown samples 
demonstrate the ability to control downstream gene expression by altering the PCM.  
To fully determine the relationship between these PCM proteins and their effects on 
cellular metabolic maintenance of the structural environment during load, gene 
expression and scaffold material properties of cells undergoing chondrogenic induction 
and long term mechanical culture were determined. Targeted knockdown of ColVI and 
DCN further enhanced the previously seen relationships between ColVI and fgf2 and 
DCN and comp expression. FGF2 could provide an additional pathway of chondrogenic 
stimulation, through increased cellular deformation. FGF2 is a highly studied protein 
(94,131), whose exact role in mechanotransduction has yet to be determined. ColVI 
knockdown also increased adamts4 expression. OA rat models display an increase in 
proteoglycan fragments throughout articular cartilage, with an increase in enzymatic 
activity (106,148). The fibrillation and OA progression in ColVI knockout models (5) 
maybe due to the increased enzymatic gene expression seen in this study. The 
overstimulation of TGF-β in non-loaded shDcn samples caused significant upregulation 
of chondrogenic and hypertrophic genes, demonstrating an increased terminal 
differentiation. This advancement towards hypertrophy may be inhibited under dynamic 
stimulation, with dynamic loading reducing the over expression of chondrogenic markers. 
Decorin is known to sequester TGF-β through its CS/DS side chain, which also organizes 
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and binds collagen molecules together (62), but the effect of decorin knockdown hasn't 
been examined on TGF signaling.  
The effect of targeted knockdown on the material properties of cell-seeded alginate 
scaffolds was contrary to what I expected, with knockdown and dynamic stimulation 
significantly increasing the bulk viscosity parameter. Decorin controls the fibrillogensis 
of collagens, therefore controlling the mechanical properties of the PCM (149). The PCM 
with DCN knockdown will accumulate more CS/DS and increase the binding capabilities 
of biglycan, which requires two GAG side chains. The increased GAG side chains within 
the PCM will cause a increase in spacing and water content, causing this increase in 
mechanical properties, as opposed to the lack of core protein which hasn't shown an 
impact on the mechanical properties of cartilage (149). The exact means through which 
ColVI and DCN are affecting the material properties needs to be further examined, to 
understand how the proteins are affecting the matrix elaboration and homogeneity 
throughout the scaffold. While, the means through which these material properties were 
created need to be determined, we demonstrated that the overall scaffold 
biomechanical composition can be specifically engineered through targeted 
subtraction of PCM proteins. 
The exact decoupling of the roles of these proteins in mechanotransduction events is 
difficult to determine due to the constantly changing physicochemical environment 
during differentiation.  These studies taken together, demonstrate the affect of individual 
proteins on the overall accumulation and organization of matrix directly impacting 
cellular mechnanoresponsiveness. We have also demonstrated the ability to determine the 
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functional roles of specific proteins at varying points of chondrogenesis and 
mechanosensing capabilities using RNAi.  
 
Further work is needed to further clarify the mechanisms through which 
mechanotransduction events are activated. To isolate the means through which ColVI and 
DCN are involved in the mechanosignaling cascade, comparison studies should be 
developed to determine the roles of these proteins in cellular mechanosensing in an 
unaltered pericellular matrix. Comparing the shift in gene expression will determine 
whether the alteration in proteoglycan and organizing protein expression is due to the 
direct contribution of these proteins or a compensatory developed PCM. Determination of 
the composition in an altered PCM is needed to fully explain the changing biomechanical 
properties. After examining the altered PCM in non-loaded and loaded samples, further 
analysis of the effect of dynamic compressive culture following the two week 
chondrogenic induction period should be examined. The involvement of DCN in TGF 
sequestration should be further studied. Hypertrophic differentiation of chondrogenic 
hMSCs is potentially due to overstimulation from growth factors, creating a difficult 
means to maintain a chondrocyte-like phenotype in vitro. Using sLRPs to control growth 
factor stimulation  of the cell could potentially help maintain phenotype within tissue 
engineered scaffolds for articular cartilage.  
Establishing the ability to specifically engineer the micromechanical and therefore the 
macroscale cell-scaffold biomechanical properties through intrinsic cellular engineering 
provides the capabilities to engineer a stratified construct for articular cartilage tissue 
engineering. Articular cartilage demonstrates varying zones of extracellular matrix 
composition and mechanical characteristics, which are hard to mimic in tissue 
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engineering. Engineering the environment through cellular control and controlling the 
biological response to mechanical stimulation can potentially improve regenerative 
therapies for articular cartilage repair.  
 
Fig. 7.2: Schematic of shRNA modified stem cells for tissue engineering. ShColVI and shDcn 
knockdown can be used for increased hypertrophic differentiation and TGF-β exposure.(As 
adapted from Noth, U, 2008 (2)). 
 
The overall goal of tissue engineering for articular cartilage repair aims to maintain 
chondrogenic phenotype within the TEC and to mimic the physiologic environment at the 
implantation site. Continuous exposure to TGF- β improves chondrogenic phenotype 
stability and has been achieved through both cell viral transduction with TGF expression 
vectors (150), pharmacologically active microcarriers (151) , or scaffolds embedded with 
TGF-β release mechanisms (152). These methods have improved chondrogenic marker 
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expression to maintain chondrogenic phenotype. Our research offers a different approach 
to controlling TGF-β exposure by adjusting the microenvironment around the cell to 
allow a higher concentration of TGF-β to reach the cell. DCN knockdown can be used to 
improve scaffold maturation of TEC by increased PG and collagen synthesis prior to 
implantation (fig. 7.2) . The increase in growth factor stimulation and improved matrix 
synthesis will aid in scaffold incorporation into focal defect sites during osteoarthritis.  
Scaffold incorporation also should mimic the physiological mechanical characteristics 
of the tissue, with scaffold stratification improving the mechanical force transmission to 
each of the layers (fig. 7.2 and fig. 7.3). Stratification procedures currently adjust the 
TEC  to mimic the different mechanical characteristics of the cartilage (153), but using 
shRNA lentiviral vectors can adjust the microenvironment in layers through cellular 
engineering (fig. 7.3). Cartilage displays depth dependent increases in tissue stiffness and 
zonal specificity for collagen and proteoglycan composition (40). The work presented in 
this thesis provides analysis at the functional roles of type VI collagen and decorin during 
chondrogenesis and mechanotransduction as well as the ability to engineer scaffold zonal 
properties of articular cartilage.                                                        
 
Fig. 7.3: Stratification strategy using shColVI and shDcn knockdown chondrocyte-like cells. 
Different composition and mechanical properties can be achieved through layering different 




Chapter 8: List of Abbreviations  
ACAN- Aggrecan 
AC-Articular cartilage 
ADAMTS- A Disintegrin And Metalloproteinase with Thrombospondin Motifs 
AMFs- Actin microfilaments 
ANOVA- Analysis of variance 
AR- Aspect ratio 
BGN- Biglycan 
BMP- Bone morphogenic protein 
CM- Chondrogenic media 
CMFDA- 5-chloromethylfluorescein diacetate 
ColVI- Type VI collagen 
COMP- Cartilage oligomeric matrix protein 
CS/ DS- Chondroitin sulfate/ dermatan sulfate 
CTCF- Corrected total cell fluorescence 
DAPI- 4',6-diamidino-2-phenylindole 
DCN- Decorin 
DMEM- Dulbecco's modified eagle's medium 
dsRNA- Double stranded RNA 
ECM- Extracellular matrix 
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EthD-1- Ethidium homodimer 
FBS- Fetal bovine serum 
FGF- Fibroblast growth factor 
FS- Free swelling 
GAG- Glycosaminoglycan 
GFP- Green fluorescent protein 
GM- Growth media 
HA- Hyaluronic acid 
hMSCs- Human mesenchymal stem cells 
IGF- Insulin growth factor 
IL- Interleukin 
MAPK- Mitogen-activated protein kinases 
MMP- Matrix metalloproteinase 
MOI- Multiplicity of infection 
MT- Microtubules 
NAR- Normalized aspect ratio 
NT- Nucleotide 
OA- Osteoarthritis 
PCM- Pericellular matrix 




qRT-PCR- Quantitative reverse-transcriptase polymerase chain reaction 
RISC- RNA induced silencing complex 
RNAi-  RNA interference 
SEM- Standard error of the mean 
shColVI- shRNA virus targeting col6a1 
shDCN-shRNA virus targeting dcn  
shRNA- Short hairpin RNA 
siRNA- Small interfering RNAs 
sLRPG- Small leucine rich proteoglycan 
TEC- Tissue engineered construct 
TGF- Transforming growth factor 
TNF- Tumor necrosis factor 
TU- Titering units 
VEGF- Vascular endothelial growth factor 














18s 111.391 R² = 0.9901 
acan 94.443 R² = 0.998 
adamts4 117.701 R² = 0.9922 
adamts5 102.704 R² = 0.9588 
bgn 95.952 R² = 0.9925 
bmp6 132.320 R² = 0.9999 
col1a1 89.766 R² = 0.9983 
col6a1 99.260 R² = 0.9949 
col6a2 95.695 R² = 0.9981 
col6a3 91.209 R² = 0.9945 
col9a2 101.487 R² = 0.9991 
comp 89.429 R² = 0.9951 
dcn 108.157 R² = 0.9948 
fgf2 102.704 R² = 0.9715 
gapdh 98.363 R² = 0.9966 
mmp13 86.513 R² = 0.978 
rhoa1 114.497 R² = 0.9911 
runx2 104.487 R² = 0.9983 
sox9 106.101 R² = 0.994 
vim 91.951 R² = 0.9964 
 
Table A.1: qRT-PCR amplification efficiencies determined through serial cDNA compared to 




Efficiency is determined from the slope of the log(cDNA concentration) versus the Ct 
value achieved by the MyIQ Biorad qRT-PCR reaction. From the linear regression line, 
the efficiency of each primer is determined using: E=(10
(-1/ pe)
-1)*100%. Primers are 




Fig. A-1: Representative figure determining primer efficiency of col6a1. The log of the 





Appendix B: Compiled Computer Aided Design of custom 




Fig. A-2: (A) Lid and (B) base of custom designed unconfined compressive bioreactor. 
Individual petri dishes are placed within each culture well of the bioreactor. The base and lid are 
concentrically placed on top of each other (C), with the Zaber linear actuator attached through the 
middle of the bioreactor. The lid's position is maintained by posts (D) to maintain the concentric 
position of the plungers above each culture well. A side view of the plungers located above the 





Fig. A-3: Engineering drawing of bioreactor base. Drawings shown are the top, bottom, and side 
views. Dimensions are in millilmeteres. All drawings were created using SolidWorks (created by 






Fig. A-4: Engineering drawing of bioreactor base. Views shown are the top and cross-sectional as 
noted. Dimensions are in millilmeteres. All drawings were created using SolidWorks (created by 





Fig. A-5: Engineering drawing of bioreactor lid. Views shown are top and cross-sectional cut as 
noted. Dimensions are in millilmeteres. All drawings were created using SolidWorks (created by 
Ben A. Bulka).  
 
Fig. A-6: Engineering drawing of bioreactor lid. Views shown are bottom, top, and cross-
sectional cut as noted. Dimensions are in millilmeteres. All drawings were created using 




Fig. A-7: Engineering drawing of bioreactor base bottom. Views shown are top and side. 
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